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Introduction
The development and the spreading of complex treatment modalities in radiotherapy, such
as Intensity Modulated Radiation Therapy (IMRT), Stereotactic Radiosurgery (SRS), and
Volumetric Modulated Arc Therapy (VMAT), have provided great achieving in reducing
dose to healthy tissues and delivering radiation targeted for very specific lesions. On the
other hand, these techniques are characterized by high dose gradients and considerable time
and space variations of dose rate and beam fluence, leading to an increase of the complexity
of treatment planning and delivery. For these reasons, more specific dosimetric solutions
are necessary to the radiotherapy treatment verification and quality assurance (QA).
Among the various types of dosimeters, at present GafChromic EBT3 films represent
one of the most powerful tools to perform QA with high accuracy and measure absolute
dose in radiotherapy. They have very high spatial resolution, weak energy dependence in
a wide photon energy range, and no angular dependence. Furthermore, radiochromic films
present the advantages of easy handling, being insensitive to room light, self-developing,
and they can be digitalized using a common flatbed charge couple device (CCD) scanner.
The characteristics of near-tissue equivalence, effective point of measurement very close to
the clinically relevant and recommended depth for skin of 70 µm [1, 2] and the possiblility
of being cut and positioned at various locations on the patient, allow to use EBT3 film as
in vivo dosimeter and evaluate skin dose during radiotherapy treatments.
This thesis aims to describe the use of GafChromic EBT3 films for pre-treatment QA
applying both single channel and multichannel methods, and to report and analyse skin
dose measurements using radiochromic film as in vivo dosimeter.
In first place, an overview of the main principles, characteristics and applications of
radiochromic films and of flatbed scanner dosimetry is provided (see Chapter 1). Secondly,
the setting out of the scanning protocol and the characterization of the scanner are described
in Chapter 2. Then, an account of the calibration measurements is given, focusing on fit
analyses performed for single channel dosimetry with red color channel. Moreover, data
calibration has been also performed with a method that combines green and blue channels
data together [3, 4] and using multichannel dosimetry [5] (see Chapter 3).
With the purpose of validating GafChromic film dosimetry method, film readings have
been compared with data measured through PTW 2D-Array 729 irradiated with different
standard fields. Afterwards, pre-treatment QA measurements have been performed with
EBT3, and absolute dose maps have been compared with TPS calculations using γ-analysis
[6] (see Chapter 4).
Finally, in vivo measurements performed during radiotherapy treatments are described.
Skin dose was evaluated on patients undergoing helical tomotherapy treatments for different
pathologies, including head and neck, brain cancer and sarcoma. Moreover, measurements
on patients with breast cancers treated at Linac both with 3D conformal radiotherapy
(3D-CRT) and VMAT, and skin lesions treated with Plesio-Röntgen therapy have been
considered. Then, in vivo measurements, analysed with GafChromic dosimetry, have been
compared with TPS planned doses, investigating on factors possibly related to discrepancies
between expected and measured doses (see Chapters 5 and 6).
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Chapter 1
GafChromic film dosimetry
The advancement and the diffusion of complex treatment modalities in radiotherapy, such as
IMRT, SRS, and VMAT, have provided great achievement in reducing dose to healthy tissues
and shorted treatment time, and have allowed dose delivery targeted for very specific lesions.
These techniques are characterized by high dose gradients, small fields, and high time and
space variations of dose rate and beam fluence, leading to an increase of the complexity
of treatment planning and delivery. For these reasons, more specific dosimetric solutions
are necessary to the radiotherapy treatment verification and quality assurance (QA) [7]. In
radiotherapy, dosimetry aims to quantifying the energy deposited in a medium in terms of
absorbed dose to water. An ideal dosimeter should be stable, insensitive or predictable in
response to environmental factors such as temperature, pressure and humidity. Moreover,
it should be small in size enough to provide high spatial information as well as producing
minimal perturbations of the beam. It should be water equivalent to allow interpretation
of dose relative to tissue and also to avoid perturbations and other artifacts. The response
to radiation is desired to be independent on energy and dose rate for Mega-Voltage (MV)
photons and electron beams, and ideally be linear in its response, with sensitivity to both
small and large doses. Other more practical considerations include that it be non-toxic for
in vivo dosimetry purposes, cheap, reliable and reproducible [8].
Among the various types of dosimeters, at present radiochromic films represent one of
the most powerful tools for QA in radiotherapy. They have high spatial resolution, weak
energy dependence in a wide photon energy range, near-tissue equivalence and no angular
dependence. These dosimeters also present the advantages of easy handling, being insensi-
tive to room light and self-developing, and they can be digitalized using a common flatbed
charge couple device (CCD) scanner equipped with a transparency unit for transmission
measurements. Nevertheless, radiochromic film dosimetry presents some disadvantages,
such as a complex and quite time-consuming processing, intrinsic film inhomogeneity and
non-uniform scanner response in the direction of the CCD array. In this chapter a de-
scription of the physical principles and applications of radiochromic films will be provided,
focusing on the GafChromic EBT3 commercial films, that at present are the most used
commercial films in radiotherapy.
1.1 Overview of GafChromic film models
Much of the early work on radiochromic materials can be attributed to the National Insti-
tute of Standards and Technology (NIST, US). In 1965 McLaughlin et al. firstly reported
on the development of colorless solid solutions of particular materials, called derivatives of
triphenyl methane molecule, that underwent radio-syntesis to produce dyes. The initial
forms of radiochromic media had a useful dose range of 103 to 106 Gy, hence their use was
limited to high dose applications such as food irradiation, medical instrument sterilization
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and other industrial applications. The possibility for new non-industrial applications ap-
peared when a new radiochromic film medium was developed in 1986. This film was named
GAFchromicTM and was produced by ISP Technology, a division of GAF Chemical corpo-
ration (GAF Corporation, Wayne, NJ). The acronym GAF was derived from the company’s
pre-1968 name of General Aniline and Film Corporation. In 1991 the GAF Chemical Cor-
poration was publicly listed and it is now known as International Speciality Products Inc.
(ISP). The particular dye in GafChromic medium was found to be an order of magnitude
more sensitive than previous types and could be used to map distributions with lower doses
occurring in medical applications [8].
The materials in radiochromic films which are responsible for the coloration are known
as crystalline polyacetylenes, in particular diacetylenes, and upon thermal annealing or
radiation exposure they undergo polymerization. The particular diacetylene monomer
which composes GafChromic EBT films is the lithium salt of pentacosa-10,12-diyonic acid
(LiPCDA) [9]. In the raw manufactured form diacetylene crystals are too large to provide
useful sensitivity, hence they are dissolved in a solvent, which has the added advantage of
improving the light resistance of the polyacetylenic crystals. These dissolved crystals are
then dispersed in a binder such as an aqueous gelation solution. After further processing
to remove the alcohol solvent the binder is coated onto a substrate, upon drying crystals
become fixed in orientation. Possible substrate materials include polyester, ceramic, glass,
and there can be additional coatings in the active layer to reduce UV sensitivity and to act
as anti-oxidizing layer [8]. McLaughlin et al. demonstrated that the emulsion mechanism
of color production in GafChromic films was a first order solid state polymerization and
reported that post-irradiation polymerization continued to occur, most notabily within the
first 24 hours following exposure [10]. The diacetylene monomers upon heating, UV or ion-
izing radiation exposure undergo progressive 1,4-polymerisation leading to the production
of colored polymer chains that grow in length with level of exposure (see Fig. 1.1). The
radiation sensitivity of the crystal is also dependent on the particular end groups, with the
lithium salt of PCDA used in GafChromic EBT being sensitive to doses as low as 1cGy,
several orders of magnitude more sensitive than the earlier radiochromic films.
ISP manufacturers a range of radiochromic films under the product name GAFchromicTM .
The difference between each type of film relates to whether it is constructed with a single or
double active layer film, if it is reflective or transmissive film, its physical dimension, and the
specific chemical composition of the active layer. In the mid 2000’s a film was released called
GAFchromicTM EBT. The active layer was a variation of the monomer used in the previous
films, and was a hair like version of the LiPCDA crystal [9]. The atomic composition of
EBT is (42.3% C, 39.7% H, 16.2% O, 1.1% N, 0.3% Li and 0.3% Cl). The inclusion of the
moderate atomic number element chlorine (Z = 17), provided a Zeff of 6.98 making it near
tissue equivalent. The new active layer was also found to have a good sensibility in a dose
range of 0.01-8 Gy. In 2009 the production of EBT film was discontinued and replaced by
EBT2. The EBT2 film had the same active component as EBT but with a yellow dye added
to the active layer and it was also constructed as a single layer instead of double (see Fig.
1.2). The film has a slightly narrower active layer than EBT and lightly different overall
atomic composition. The Zeff of EBT2 is 6.84 compared to 6.98 for EBT, and close to Zeff
of water (7.3). Several works have been published studying some EBT and EBT2 properties,
such as film homogeneity [11, 12], scanning orientation dependence [13–17], energy depen-
dence [14, 18–20], absorption spectra [21], postcoloration behavior [12, 14, 15, 17, 18, 22, 23],
high-dose dependence [17], temperature dependence [9, 17, 24] and ambient light sensitiv-
ity [17].
In 2011, ISP released a new film generation, the GAFchromicTM EBT3 film (see Fig.
1.3). This film is made by laminating an active layer between two identical polyester layers,
which makes the product more robust and allows water immersion. While the active layer
3
Figure 1.1: The diacetylene monomers undergo a 1,4 polymerization upon exposure to heat,
UV or ionizing radiation [8].
Figure 1.2: An illustration of the physical configuration of GAFchromicTM EBT compared to
EBT2. EBT2 has a slightly thinner active layer and an asymmetric design [8].
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composition and response are unchanged, the real EBT3 improvements are: the symmetric
structure that will avoid the potential errors in optical density measurements due to scanning
side in EBT2, the matte polyester substrate that prevents Newtons Rings formation, and
the presence of fiducial marks that allows for the film automatic alignment if required [25].
The dynamic range of this film is designed for best performance in the dose range from 0.2
to 10 Gy, making it suitable for many applications in IMRT, VMAT and brachytherapy. For
measurement of doses substantially greater than 10 Gy other GafChromic film models are
preferred, such as EBT-XD or MDV3, while the use of HD-V2 is indicated for still higher
dose measurement.
The structure of EBT3 film is shown in Fig. 1.4. The film is comprised of an active layer,
nominally 28 µm thick, sandwiched between two 120 µm matte-polyester substrates. The
active layer contains the active component, a marker dye, stabilizers and other components
giving the film its near energy independent response. The thickness of the active layer
will vary slightly between different production lots. The yellow marker dye incorporated
in EBT3, in conjunction with a Red Green Blue (RGB) film scanner and a commercial or
homemade software, enables the dosimetry process to benefit from the application of triple-
channel dosimetry [28]. The polyester substrate of EBT3 has a special surface treatment
containing microscopic silica particles that maintain a gap between the film surface and
the glass window in a flatbed scanner. Since the gap is nearly ten times the wavelength
of visible light, formation of Newton’s Rings interference patterns in images acquired using
flatbed scanners is prevented.
Dosimetric study on EBT3 performed by Casanova Borca et al. [25] confirms that the
red channel has a greater response up to 10 Gy. The green channel exceedes the red one
for doses above 10 Gy, indicating it could be preferable to use the green channel at higher
doses. Instead, the blue channel has a lower response gradient at any dose because the
signal has a weak dose dependence while having a strong dependence on the thickness of
the active layer. This makes the blue channel less useful than the other channels for dose
measurements. In addition, measurements of postirradiation development with time have
been reported in literature. Regarding this aspect, EBT3 films showed the same behavior as
EBT2 [17,23]. Casanova Borca et al. reported that between 24 h and 72 h after irradiation
the variations in net optical density (net OD, see Eq. 1.2) were less than 0.005 for all doses
between 0.3 and 4 Gy. Then they studied the variation of net OD measured at 30 min, 1
h, 2 h, 6 h after irradiation with respect to net OD measured 24 h after irradiation. They
showed that between 1 h and 24 h after irradiation, the variations in net OD were less than
0.010 for all doses under study. Moreover, between 2 and 24 h after exposure, changes in
the net OD were less than 0.008 (see Fig. 1.5) [25].
Finally, Casanova Borca et al. [25] demonstrated that EBT3 film response is nearly
independent on radiation energy used in IMRT treatments, within the uncertainty of the
measurement, thus confirming previously published data on EBT2 [20]. Differences be-
tween films were negligible with values less than 1% for doses up to 4 Gy, comparing 6
MV and 15 MV energies and three different dose rates (100 MU/min, 300 MU/min, 600
MU/min). Other studies have been set up on EBT3 energy dependence considering both
the MV and the Kilo-Voltage (KV) regions. Rubinstein et al. showed that in KV region,
EBT3 has significant energy dependence showing decrease in film-sensitivity with decreas-
ing beam energy. However, the film resulted practically energy independent for MV Photon
& Electron beams including Cs-137 [26]. Furthermore, Villarreal-Barajas et al. reported
that for a given dose of 1 Gy of kVp Xray, the response relative to Co-60 using the three
color channels decreases with decrease in kVp, reaching a maximum under response of about
20% for the 70 kVp. A significant under response of about 5% was observed at 300 kVp.
Instead, responses of MV Xray beams with respect to Co-60 at the 1 Gy dose level showed
no statistically significant difference [27].
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Figure 1.3: GafChromic EBT3 available in format: 8”x10”, 25 sheets/box (Ashland, Medical
dosimetry, www.gafchromic.com).
Figure 1.4: Configuration of GafChromic EBT3 dosimetry film (www.gafchromic.com).
Figure 1.5: Variation of net optical density after 30 min, 1h, 2 h, and 6 h compared to 24 h
after irradiation at eight different dose levels [25].
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1.2 GafChromic film dosimetry system
As for other types of dosimeters, by using a certain protocol a radiochromic film dosimetry
system can provide a measurement of absolute dose. However, to convert the response
of the film into absolute dose, the calibration curve is needed. It has to be determined
for a given radiochromic film dosimetry system, which consists of a film model, particular
densitometer used, and protocol together, under reference conditions and using a reference
radiation beam quality. The very same motive is applied to other dosimetric systems in
the clinic. On the other hand, absolute dosimeters report an absolute dose as a result of
dose measurement without an a priori knowledge of the dosimeter’s response to a certain
reference beam quality. Up to now, absolute dosimeters have been designed, developed and
maintained in Radiation Standard Laboratories only. Currently used absolute dosimeters
are: Free Air Ion Chamber, Calorimeters and Fricke-gel dosimeters [29].
Response of radiochromic films to radiation is commonly expressed in terms of the change
in its optical density (netOD), that represents the difference in optical densities of the same
film piece sampled after and before irradiation. The optical density (OD) is the function
of the wavelength at which the absorbance was sampled. In other words, the measured
OD could be considered a sole property of the film only if sampled by spectrophotometer
where the measured OD refers to the particular wavelength of the absorption spectrum. On
the other hand, many optical densitometers are employed (particularly flatbed document
scanners) that use broad band fluoroscopic visible light sources. For the optical densito-
meters that do not employ monochromatic light sources, OD change is a rather complex
convolution between the film absorption spectrum (A(λ)), the linear CCD array sensitivity
spectrum (S(λ)) and the emission spectrum of the fluorescent light source of the scanner
(E(λ)), which can be expressed as [29]:
OD = log10
I0
I
= log
( ∫ +∞
−∞ E(λ) · S(λ) · dλ∫ +∞
−∞ E(λ) ·A(λ) · S(λ) · dλ
)
, (1.1)
where I0 and I are the incident and transmitted light intensities respectively. It is important
to remark that for every particular radiochromic film dosimetry system the sensitivity curves
will be different [30]. One should also remember that manufacturer may change the chemical
composition of the film layers. So even for the same film model, the sensitivity and hence the
calibration curve may change from one film batch to the other. In fact, a good practice is to
measure a new calibration curve if the film batch has changed, indicated by manufacturer
on the box.
OD depends on the thickness of the film, but also on the wavelength of the incident
light. Radiochromic films have an inherent color that develops during radiation exposure,
and the optical absorption varies by wavelength [23]. OD is determined using a color flatbed
scanner which digitalizes the image and measures the film response over different wavelength
bands divided into red, green and blue in the visible spectrum. The absorbance spectrum
of the active layer for GafChromic EBT3 has a peak of 636 nm after exposure to ionizing
radiation, which means that the maximum sensitivity for optical density measurements is
obtained with the red color (see Fig. 1.6).
The process of radiochromic film dosimetry can be divided two distinct steps. Firstly,
the generation of the calibration curve, during which film samples are irradiated to known
dose values. In second place, an irradiated film with unknown dose can be read apply-
ing the calibration curve. During the calibration phase, a reference radiation source must
be used, which has been previously calibrated following an a priori established reference
dosimetry protocol (TRS 398 [31] or TG-51 [32], for example). Once the radiation source is
characterized, reference irradiation takes place by exposing several pieces of film to different
dose values. Pixel values (PV) of the transmission scan on a flatbed document scanner are
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Figure 1.6: Absorption spectra of EBT3 film as a function of wavelength, before exposure
(the yellow line) and after irradiation corresponding to 2.0 Gy (the green line)
http://www.rpdinc.com/.
sampled over predefined region of interest (ROI) and change in OD is calculated for every
film piece:
netOD = ODafter −ODbefore = log10
PV0
PVafter
− log10
PV0
PVbefore
= log10
PVbefore
PVafter
, (1.2)
where PV0 represents the pixel value of non attenuated beam and for a 16-bit image amounts
to 216. To use the calibration results for future dose measurements, the common practice
with GafChromic films is to plot dose as a function of the measured netOD, and then fit the
data with an appropriate function using the method of least squares. Fig. 1.7 illustrates
schematically the reference dosimetry protocol established to measure absolute dose of a
plan dose distribution in an IMRT plan using only the red channel of the scanned RGB
image. The use of the red color channel is commonly adopted in the current practice, but it
does not exclude the possibility of using the other color channels, especially if higher doses
are to be measured with a given radiochromic film dosimetry system.
1.2.1 Flatbed scanner dosimetry
To determine the amount of dose delivered to a film, its change in the absorbance is mea-
sured. In order to quantify this change the optical density of the film needs to be measured
using a scanning densitometer system. The ready availability and low cost of flatbed scan-
ners make them attractive for use as densitometers. One particular make and model, the
EPSON 10000XL, has been specifically recommended by ISP for use with their GafChromic
EBT films.
A flatbed scanner is usually composed of a glass pane (or platen), under which there is
a white light fluorescent source which illuminates the pane, and CCD detection system that
move together to scan the film. The movement direction of the light source will be called
the y-axis and the direction parallel to the light source the x-axis (see Fig. 1.8). The unit
contains a combined mirror-lens optics forming a reduced image of the illuminated line of
the scanned object on a CCD detector array. These devices can operate in transmission
or reflection mode. The most basic difference between transmission and reflection mode is
that in reflection mode most of the detected light has passed through the film twice, this
increases the sensitivity to low doses but leads to quicker saturation at higher doses. The
image produced by a CCD scanner is usually of 16-bit resolution in the channel of interest,
for a color channel this will mean 48-bit images are required as 16-bits will be allocated to
each of the red, green and blue color channels.
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Figure 1.7: Summary of radiochromic film reference dosimetry protocol. Top: calibration of
radiochromic film dosimetry system. Bottom: measurement of an unknown map
of dose [29].
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Fluorescent light sources can have an emission spectrum that covers the entire visible
spectrum and may include ultraviolet and infrared. Fig. 1.9 shows the emission spectrum
for the Xenon cold cathode ray tube that is found in the Epson 10000XL scanner type, also
shown are the spectral sensitivities in the red, green and blue channel for the CCD typically
used in flatbed scanner. As can be noticed, the red channel is well suited for GafChromic
dosimetry with a peak sensitivity between 600-650 nm [8].
OD range and Warm-up
As described by Gonzalez et al. [36], the OD range of a scanner used for film dosimetry is
limited to saturation and noise. As the OD increases, saturation causes the rate of change
of the output to become smaller as the input signal increases, whilst at the same time
the amount of noise remains fairly constant or increases. The combined effect leads to a
degradation of the signal-to-noise ratio at high optical densities. The nominal maximum of
OD for the EPSON 10000XL scanner is of 3.8.
A warming up period has been observed for scanner fluorescent lamps. If possible the
scanner and lamp should be turned on 30 minutes prior to use to allow the temperature to
stabilize. For some scanners, such as the EPSON 10000XL, it is not possible to indepen-
dently switch the light source on without scanning, hence to warm up the lamp scanning
must be performed. Typically the scanner response stabilizes after the first 3-4 scans. Sev-
eral authors report various scanning methodologies, but each contains either a warm-up
period or the rejection of the first 2-3 images, followed by averaging of the next 3 images [8].
Noise
In addition to the microscopic non-uniformity of the film, the flatbed scanner will introduce
additional noise due to electronics. By averaging multiple successive scans the amount of
noise can be reduced [37, 38]. Ferreira et al. reported that a large decrease in noise was
achieved by repeating scans twice, and a maximum improvement occurred after 4 scans. As
the number of repeated scans increased beyond four there was degradation in image quality
and the noise became to increase again [8].
To reduce noise caused by imperfections in the film the images can be processed using
a filter, such as Wiener filter [37]. The 2D Wiener filter uses a local estimate of the noise
power spectrum and is therefore suitable for dosimetry as it preserves systematic variations
in the film’s OD. To minimize film to film variations, averaging across multiple films can be
done. In a study by van Battum et al. on EBT and the uncertainties associated with using a
flatbed scanner they concluded that using at least two films reduced the impact of inherent
film non-uniformity and reduced the overall uncertainty of EBT dosimetry down from 1.8%
to 1.3% [39]. Decreasing scanner resolution can also improve dose accuracy by averaging
out the noise. Using a resolution of 72-75 dpi provides a good compromise between image
resolution and noise [38,40].
Stability
The stability of scanners have been studied by performing numerous repeat scans. When
using radiochromic film a gradual increase in OD was observed following the initial warm-up
period. Several factors contribute to this growth. The response of the film is temperature
dependent, as multiple scans are made the temperature of the glass plate increases and then
the film also heats up leading to a change in response [24]. Another contributing factor to
the increase in OD with multiple successive scans is the presence of UV wavelengths in the
fluorescent light. Most radiochromic films demonstrate some sensitivity to UV light, and
when they are scanned using the standard white light fluorescent tube the UV component
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(a) (b)
Figure 1.8: The Epson Expression 10000XL flatbed scanner. (1.8a) The scanner bed, the
coordinates y (movement direction of the lengthy light source) and x (parallel to
the lengthy light source) and the movable imaging unit below the lengthy light
source. (1.8b) Cross section (not to scale) of the light recording unit. Its box has a
width of 15.8 cm, length of 39 cm and height of 8 cm. It moves in the y direction,
and the x direction is perpendicular to the drawing plane [35].
Figure 1.9: Typical spectral sensitivities of the red, green and blue channels of a CCD of the
type used in flatbed scanners, also shown is the emission spectrum of the Xenon
cold cathode ray tube used in the EPSON 10000XL flatbed scanner [8].
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results in additional polymerisation. Limiting the number of scans to fewer than 10 will
minimize this effect [8].
Uniformity
The non-uniformity of the scanned light field on flatbed scanners has been well documented
and it is one of the largest sources of error if left uncorrected [24]. The non-uniformity is
essentially limited to the direction perpendicular to the scan direction (x-axis in Fig. 1.8),
this being parallel to the light source. The non-uniformity has been shown to be dependent
on OD and can be greater than 10% across the entire scan area. The non-uniformity study
across the EPSON 10000XL scanner will be extensively described in the second chapter.
However, the effect of this non-uniformity is that the pixel value behaviour along the x-axis
has a parabolic trend, with the maximum located in the central axis of the scanbed.
Devic et al. suggest several possible contributing factors to the non-uniformity: geomet-
rical inefficiency with CCD elements at the edge capturing fewer photons, light leackage,
diference between reflections in the central region and in region close to the edges of the
scanning bed and the optics used to focus the light at the CCD array [8, 47]. To minimize
the uncertainty associated with light non-uniformity, several methods have been suggested.
The simplest method is to scan the films in the centre of the scanner which has minimal
non-uniformity. An alternative approach is to is to use a transparent film or filter of constant
OD, and scan it over the entire flatbed producing a correction matrix.
Orientation
Landscape orientation of the film means that the long side of the film points in the x
direction, while in portrait orientation the long side is pointing in the y direction. The scan
response of radiochromic films is sensitive to orientation of the film on the scanner. This
behaviour is caused by the anisotropic scattering of the photons emitted by the scanner when
passing through the polymer network, and the polarization of the transmitted light by the
needle-like shape particles of film active component that are preferentially aligned parallel
to the direction in which the film was coated that is parallel to the short edge of the film.
Casanova Borca et al. reported that EBT3 film shows a difference up to 4.5% in net OD
between portrait and landscape orientation [25]. Measurements showed lower dependence
to those published for EBT2 by Andreas et al. (≈7-9%) [17], although greater than that
published by Desroches et al. (≈2%) [16]. Moreover, Schoenfeld et al. scanned EBT3
films exposed to doses between 0 Gy and 20.9 Gy and placed on the scanner in landscape
and portrait orientation, also with and without the application of a neutral density filter
to correct non-uniformity (see Fig. 1.10 for results). By comparing between landscape
and portrait orientation the optical densities measured at the same dose, the orientation
effect can be recognized: the measured optical density is always higher when the film is
scanned in portrait orientation. The parabola effect, on the other hand, is represented by
the lateral increase of the measured optical density, shaped as an upward-bent parabola
with its deepest point near the centre of the light source and with a dose-dependent weight
of the quadratic term. An increase in optical density towards the ends of the x-axis of up
to 8.4% for landscape orientation and up to 12% for portrait orientation was observed [35].
Conversely, due to the symmetric structure of EBT3, differences from film face-up versus
face-down scan orientation were negligible, with values less than 0.7% for doses up to 4
Gy [25]. The side independent scanning can be considered the most important improvement
of EBT3 film with respect to EBT2, which showed a net OD difference between the two
sides approximately equal to 2% which may significantly affect relative and absolute dose
measurement [16]. In practice, the EBT3 film can be scanned with either side facing the
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Figure 1.10: The orientation and parabola effects in landscape (a) and portrait (b) orientation
of EBT3 films exposed to doses from 0 to 20.9 Gy (full lines), in comparison with
scans of neutral density filters with different optical densities (dotted lines) [35].
light source, but in the measurement and analysis of calibration, care must be taken not to
mix films acquired in portrait orientation with those acquired in landscape.
Spatial resolution
It has been reported that the active component of GafChromic film is capable of resolving
greater than 1200 lines/mm, due to the physical size of the crystal [10]. When dispersed
in emulsions of different thickness the true resolution is likely to deviate from this value.
In either case Gafchromic film is capable of very high spatial resolution, and for accurate
dosimetry the film response should be uniform over very small and large distances. Hence
the spatial resolution is only limited by the scanning resolution, which is 2400 dots per inch
(dpi) for the EPSON 10000XL. Nevertheless, Ferreira et al. reported that as the resolution
of the scanning system decreased the amount of noise also decreased, as determined by the
standard deviation within a ROI (2x2 mm2) for EBT2 film (see Fig. 1.11) [38]. This is the
reason why the most common values for scan resolution are 72-75 dpi, which correspond
roughly to 0.3 mm.
1.3 Radiochromic films applications
Radiochromic film has been used for a variety of medical applications, but with the advent
of the GafChromic media and the even more sensitive EBT3 product, there has been a rapid
uptake of radiochromic film for use in radiotherapy dosimetry.
For accurate quantitative dosimetry to be performed with radiochromic film there must
be adequate measures in place to account for the variety of film and densitometer dependent
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Figure 1.11: Profiles measured across the same region of GafChromic EBT2 film using differ-
ent scan resolutions. As the scan resolution decreases the amount of noise also
decreases [8, 38].
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properties. With such measures in place radiochromic film can be adopted to collect high
resolution data that characterizes various properties of the linear accelerator, such as micro-
multileaf leackage and trasmission, to perform small stereotactic field dosimetry [8,42], and
proton beam dosimetry. The water resistance and near tissue equivalence of EBT3 films
allow them to be used in water phantoms to perform accurate dosimetry.
The high resolution of GafChromic film makes it favourable for performing high resolu-
tion qualitative measurments. GafChromic film has been used to verify isocentre alignment
for proton beams, on linear accelerators also, and for periodic QA in Tomotherapy.
There have been a number of published papers describing the use of GafChromic films
in brachytherapy. In this field they have been used to determine the TG-43 parameters for
the Cs-131 and Cs-132 seed sources [45], and to access dose heterogeneity in intra-operative
HDR brachytherapy and for high dose rate (HDR) brachytherapy QA.
One of the most common uses of GafChromic films is to perform quality assurance
of IMRT treatments, for which EBT films were specifically designed. With the complex-
ity of IMRT planning and delivery requiring increased verification of treatment delivery,
radiochromic films provide a fast and reliable mean of accurately recording the dose dis-
tribution. The insensitivity to room light and lack of chemical processing also allow it to
be incorporated into a variety of phantoms. Moreover they are used for pre-treatment QA
in SRS and VMAT, and thanks to their high spatial resolution they are suitable for small
lesions typical of Stereotactic RadioTherapy (SBRT).
In addition to its use for verifying patients treatments, radiochromic film shows a great
potential for two dimensional clinical dosimetry of electron beams [43, 44], and it has been
found useful in total skin electron therapy (TSET) in vivo [45]. Radiochromic films can
be also used to measure not only the small electron cutout output, which represents very
labor intensive and time consuming process, but, it provides complete dose distribution
within measuring plane that may help radiation oncologist in dose prescription from a given
treatment.
The ability to cut and bend the film allows it to be positioned at various locations on
the patient and have challenging dosimetry, such as skin folds. In fact, GafChromic films
have many attractive characteristics that make them candidates for in vivo skin dosimetry
such as, high spatial resolution, near-tissue equivalence, weak energy response, angular
independence. Moreover, the equivalent depth in water of the effective point of measurement
for EBT radiochromic films has been determined as 153 µm [47], which is very close to the
clinically relevant depth for skin of 70 µ recommended by ICRP [1] and ICRU [2]. For
example, Su et al. have applied GafChromic EBT as an in vivo dosimeter in total body
irradiation (TBI) dosimetry to evaluate entrance and exit doses in various locations of
patient surface. Moreover, Avanzo et al. performed in vivo measurements to evaluate dose
to the skin in helical tomotherapy [46]. In this study the sites of treatments included scalp,
brain, head and neck, cranio-spinal axis and lower limbs. To give another example, Roland
et al. measured and compared skin dose for prostate and head-and-neck patients treated
on various IMRT delivery systems (serial and helical tomotherapy, IMRT step and shoot),
observing that the TPSs always overestimate the average skin dose in all three systems [48].
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Chapter 2
Flatbed scanner characterization
In this chapter the preliminary measurements performed to characterize the flatbed scanner
are described. The scanner response has been studied in terms of reproducibility, stability
and uniformity. Moreover, the variation of the mean pixel readout between consecutive
readings and between different protocols was evaluated for the three colour channels with
the aim of setting up a general scanning protocol for the dosimetric readings.
2.1 Reading protocol
A flatbed scanner, Epson Expression 10000XL (Seiko Epson Corporation, Nagano, Japan),
and its software, EPSON Scan v3.49I, were used to digitalize the films (see Fig. 2.1 and
2.2). The EBT3 were scanned in professional mode, which gives the greatest control of
image colour and quality, and the scanning parameters were set as follows:
• film type: positive film;
• spatial resolution: 75 dpi;
• type of image: colour 48-bit;
• document dimensions: width 419.1 mm, height 309.9 mm.
All filters and image enhancement options were turned off and the scans were saved as
tagged image file format (TIFF). The films were scanned in portrait orientation (i.e., long
edge of the film parallel with the long edge of the scan bed), which have been shown to be
more sensitive to changes in the optical density of the film [33]. A polycarbonate frame with
markers in correspondence to the centre of the scanner were developed to guarantee a good
reproducibility in film positioning on the scan bed. Since the films were scanned in colour
48-bit mode, each Red Green Blue (RGB) image was composed by three 16-bit matrixes, in
which red, green and blue signals are added together in various ways to reproduce a deep
array of colours. Hence, each pixel of a single colour matrix assumes a value in the range [0
, 216 − 1].
2.2 Preliminary measurements in the centre of the scan bed
In first place an evaluation of the necessity of a scanner warm-up in order to obtain a stable
pixel value response was performed. The same irradiated EBT3 film was scanned in three
different conditions:
1. the scanner is turned on, then, after 30 minutes of warm-up and 5 blank scans, 15
consecutive measurements of the film are taken;
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Figure 2.1: Scanner Epson Expression 10000XL (Seiko Epson Corporation, Nagano, Japan),
https://www.epson.it.
Figure 2.2: The EPSON Scan dialog box.
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Figure 2.3: Scan of an irradiated Gafchromic EBT3 film. The measurements of mean and
standard deviation of pixel values is computed in a fixed central ROI with area of
50x50 pixels.
2. the scanner is turned on, then the film is scanned 15 consecutive times;
3. the scanner is turned on, then, after 30 minutes of warm-up, 15 consecutive scans of
the film are made.
Each group of measurements has been acquired in about 15 minutes and distant in time
from the others. The mean and the standard deviation of the pixel values in a Region Of
Interest (ROI) of 50x50 pixels taken in the centre of the film have been computed with
ImageJ software (https://imagej.nih.gov/ij/) for each set of measurements and for each
channel (see Fig. 2.3). The results of the measurements, shown in Fig. 2.4, demonstrate
that the responses in the red and green channels are quite stable if compared with the
results in the blue channel, where a slow growing trend can be appreciated in the three
sets of measurements. Considering the blue channel only, the average pixel values appear a
little more stable in the first condition, leading to prefer the first measurement approach.
Nevertheless, the differences between the results obtained in the three approaches are so little
highlighted that it can be concluded that the scanner warm-up will not substantially change
the results in terms of pixel values of the scanned film, especially if they will be averaged in
a ROI and between a small group of consecutive scans. To be thorough, the results in terms
of mean and standard deviation in the three measurements conditions between the various
scans are summarized in Table 2.1. Moreover, the results have been presented in terms of
maximum deviation from the mean pixel value and expressed in percentage (see Table 2.2).
From these it is confirmed that the more stable result in the blue channel is obtained from
the approach 1, but here the maximum deviations in the red and green channels are a bit
larger than those obtained with protocols 2 and 3. Then, to reach a compromise between
these situations, we decided to follow the first protocol. Hence, after a period of about
30 minutes of warm-up of the scanner and after a couple of blank scans, we acquired the
desired film.
2.3 Studying the reading response along the scan bed
With the aim of characterizing the response of the scanner along x and y directions (see
Fig. 2.5) for the three colour channels, the same piece of film has been scanned in various
positions along both the axes. Moreover, in order to understand the dependence of the
readout both on the position of the film and on its mean pixel value, that is inversely
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Figure 2.4: Comparison of the mean pixel values in the central ROI of 50x50 pixels between
the three measurement conditions (1, 2 and 3) and the three channels with respect
to the number of scans.
Table 2.1: Comparison of the global mean pixel values (PV) and standard deviations in the
central ROI of 50x50 pixels between the three measurement conditions (1, 2 and 3)
and the three channels.
Color channel Measurement 1 Measurement 2 Measurement 3
Red 19343± 18 19339± 25 19364± 18
Green 24063± 24 24047± 29 24110± 25
Blue 19090± 54 19096± 76 19109± 84
Table 2.2: Comparison of the maximum deviation from the mean of the average pixel values
in the ROI between the various measurement conditions (1, 2 and 3) and for the
three channels.
Color channel Measurement 1 Measurement 2 Measurement 3
Red 0.18% 0.15% 0.11%
Green 0.17% 0.14% 0.11%
Blue 0.29% 0.38% 0.36%
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Figure 2.5: Definition of x and y directions of the scanner. The y axis coincides with the scan
direction, instead the x axis is transversal to it.
proportional to the exposed dose, a set of square pieces of EBT3 films were irradiated at
different uniform doses. For this purpose, seven film samples of 5x5 cm2 were cut from
the same film and irradiated perpendicularly with a 10x10 cm2 open field from a 6 MV
radiation beam (Linac Synergy Agility, Elekta) to seven levels of uniform doses. Hence,
the film pieces presented different OD levels, within a range of [0.2,1.4] for red, [0.2,1.1] for
green and [0.4,0.9] for blue channel. For the sake of simplicity, they were called level 1 to 7
with increasing dose and OD.
2.3.1 Response along the scan direction
With the aim of studying the scanner reading in the motion direction of its light source,
each film sample was scanned in five consecutive positions to cover the length of 25.4 cm
every 5 cm along the y axis. The film in each position was scanned five times, then the
mean and the standard deviation of the pixel values were evaluated in a ROI of 50x50
pixels (about 1.7x1.7 cm2 with 75 dpi) placed at the centre of the piece of film. These
evaluations have been repeated for the three colours to assess eventual differences in the
channels behaviours. The design of the measurements is clarified in Fig. 2.6, and the plots
of the results at different doses are reported in Figures 2.7, 2.8 and 2.9 for red, green and
blue channels respectively. To allow a comparison between the figures, the size of the range
of the y axis has been set equal for all of them and the mean PV have been normalized to
the central value. As can be appreciated from these figures the trend of the measurements
is rather constant. Moreover, the average PV for each dose level and for each channel have
been computed (see Table 2.3). As can be seen, the percentage errors on the mean PV
are below the 0.5% for all the dose levels and for all the channels, leading to consider the
conclusion of a constant scanner reading signal along the y axis to be reliable. Moreover, it
can be noticed that the signal is a bit noisier when the exposure level of the film is lower.
2.3.2 Response along the x direction of the scan bed
With the intention of assessing the scanner behaviour on the x axis, each film sample was
scanned in four consecutive positions to cover the length of 20.4 cm every 5 cm along the
x axis. In each location the film was scanned five times and the mean and the standard
deviation of the PV were evaluated in a ROI of 50x50 pixels located at the centre of the
piece of film.
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Figure 2.6: Experimental set up for the study of the scanner readout along its axes and with
film portions (5x5 cm2) exposed at different doses, hence having different OD
levels. The mean PV was evaluated in a ROI centred in each piece and sized
50x50 pixels (about 1.7x1.7 cm2 with 75 dpi).
Figure 2.7: Evaluation of mean PV normalized to the central value along the y axis for seven
OD levels for the red channel.
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Figure 2.8: Evaluation of mean PV normalized to the central value along the y axis for seven
OD levels for the green channel.
Table 2.3: Comparison of the percentage variations of the mean PV along the y axis between
the channels and for different OD levels.
OD level Red Green Blue
Level 1 0.2% 0.2% 0.2%
Level 2 0.2% 0.1% 0.5%
Level 3 0.2% 0.3% 0.5%
Level 4 0.3% 0.2% 0.4%
Level 5 0.5% 0.2% 0.5%
Level 6 0.01% 0.04% 0.3%
Level 7 0.01% 0.04% 0.02%
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Figure 2.9: Evaluation of mean PV normalized to the central value along the y axis for seven
OD levels for the blue channel.
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Red channel
Firstly, the measurements in the red channel have been analyzed. The mean PV showed a
parabolic trend with a decrease of the readout proportional to the distance from the centre
of the scanner. Moreover, the difference in PV from the periphery to the centre was more
accentuated when the mean OD increased, reaching for example the 14% less than the signal
at the centre when considering OD level 7 at distance of 8 cm from the central axis, which
corresponds to an increase in dose of about the 20% . This result is not surprising, in fact
several authors have applied parabolic corrections in the direction of the CCD camera for
the red channel [13, 24, 47, 49–53, 65], because such deviations would considerably alter the
resulting dose map. Therefore, data were firstly fitted with a parabolic curve with three
parameters (y = p1x2 +p2x+p3) to verify that the maxima were at the centre of the scanner
(see Fig. 2.10 and Table 2.4 for the results), then a two parameters fit with a fixed point
of maximum was applied. The x coordinates of the maxima (xmax) were computed from
the fitted curves and the mean value was obtained from the three highest OD level curves,
where the best fits were obtained. The mean xmax was 10.2 cm, then the fits were repeated
with the curve y = ax2− 2xmaxa+ c, with the aim of achieving a consistent correction map
for those points on the scan bed that are not in the central axis. The results of these fits
are showed in Fig. 2.11 and Table 2.5. The fitted parables normalized at the maximum
are shown in Fig. 2.12, where it is evident the need of a parabolic correction when the
mean OD and the dose increase. From the fitted parameters, a parabolic correction method
can be set up. With this purpose, the parameters a and c should be fitted with respect
to a quantity that is proportional to the dose, such as the maximum pixel value of the
correspondent parabola (see Fig. 2.13 and Table 2.6 for the results of these fits). The idea
of the correction is that each PV of a new map will be corrected proportionally both to its
value and to its distance from the central axis. This will be done calculating the parameters
a and c of the parabola from the PV and then a correction factor k such that k · PV will
be equal to the pixel value at the centre of its parabola. More in detail, if xi is the position
of the pixel, PV its scanned pixel value and f its parabola, the correction factor k will be:
k =
f(xmax)
f(xi)
=
c− ax2max
ax2i − 2xmaxaxi + c
. (2.1)
k will always be major than 1, in fact the pixel values must be augmented proportionally
to their distance from the central position and to the correspondent dose. Therefore, the
dose associated with the corrected PV will be lower than the value that it would have had
without a parabolic correction. This method makes the approximation of estimating the
parabola for each pixel from its PV, but this value is always lower than the real one that
would be necessary for a more correct calculation of the parameters, that have been fitted
with respect to the pixel value on the central axis. This correction method will be applied
to pre-treatment QA dose maps, that will be discussed in one of the next chapters.
Green and blue channels
The mean and the standard deviation of the pixel values extracted from the ROIs located
along the x axis have also been analyzed in the green and blue channels for the various
OD levels. Here, differently from the red channel, the deviations from the mean PV in the
central axis are less pronounced. The plots of the mean PV normalized at the maximum
value with respect to the x coordinate are reported in Fig. 2.14 and 2.15 for both channels.
As it can be noticed, the average deviations from the maximum value are of 1-2% for the
green channel, and of 1-3% for the blue one. Moreover, it is not evident a trend in the
measurements but the it is clear that the blue channel is noisier than the others. It cannot
be easily and reliably identified a correction method for the deviations from the maximum
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(a) Red PV versus x position, OD level 1. (b) Red PV versus x position, OD level 2.
(c) Red PV versus x position, OD level 3. (d) Red PV versus x position, OD level 4.
(e) Red PV versus x position, OD level 5. (f) Red PV versus x position, OD level 6.
(g) Red PV versus x position, OD level 7.
Figure 2.10: Parabolic fit (y = p1x2 + p2x+ p3) of the PV versus the position along the x axis
at various OD (level 1 to 7).
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Table 2.4: Results of the parabolic fit (y = p1x2+p2x+p3) of the PV versus the position along
the x axis at various OD levels. The estimated values of the coefficients (with 95%
confidence bounds), the R-square and the position of the maximum are reported.
OD level p1 p2 p3 R-square xmax (cm)
Level 1 -8.838 155.4 4.077× 104 0.9092 8.8
(-47.34, 29.66) (-610.5, 921.3) (3.772 ×104, 4.381 ×104)
Level 2 -6.523 133.2 3.568 ×104 0.8277 10.2
(-45.3, 32.25) (-638.9, 905.2) (3.241 ×104, 3.894 ×104)
Level 3 -7.718 149.6 2.572 ×104 0.9977 9.7
(-12.41, -3.024) (54.53, 244.7) (2.536 ×104, 2.608 ×104)
Level 4 -9.764 194.9 1.664 ×104 0.9596 10.0
(-35.21, 15.68) (-327, 716.7) (1.445 ×104, 1.884 ×104)
Level 5 -10.49 214.5 1.171 ×104 0.9998 10.2
(-12.62, -8.358) (166.7, 262.3) (1.147 ×104, 1.195 ×104)
Level 6 -12.42 254.1 6502 0.9994 10.2
(-16.45, -8.384) (171.3, 336.8) (6139, 6864)
Level 7 -13.68 282.3 4755 0.9999 10.3
(-15.44, -11.93) (246.3, 318.3) (4597, 4913)
Table 2.5: Results of the parabolic fit (y = ax2 − 2xmaxa + c) of the PV versus the position
along the x axis at various OD levels. The estimated values of the coefficients (with
95% confidence bounds) and the R-square are reported.
OD level a c R-square
Level 1 -7.602 4.06×104 0.6009
(-26.45, 11.25) (3.918×104, 4.204×104
Level 2 -6.527 3.568×104 0.8277
(-15.59, 2.533) (3.494×104, 3.641×104
Level 3 -7.462 2.567×104 0.9384
(-13.28, -1.645) (2.525×104, 2.608×104)
Level 4 -8.981 1.664×104 0.9654
(-14.15, -3.81) (1.627×104, 1.701×104)
Level 5 -10.45 1.172×104 0.9997
(-11.03, -9.87) (1.167×104, 1.176×104)
Level 6 -12.43 6508 0.9992
(-13.51, -11.35) (6421, 6596)
Level 7 -13.77 4780 0.9971
(-16.03, -11.5) (4607, 4952)
Table 2.6: Results of the fits of the parameters a and c of the parabola versus the maximum
PV. The theoretical curves, the values of the parameters (with 95% confidence
bounds) and of the R-square are reported.
parameter fit function fitted parameters R-square
a f(z) = p1z4 + p2z3 + p3z2 + p4z + p5 p1 -2.686×10−17 (-4.204×10−17, -1.169×10−17) 0.9995
p2 2.586×10−12 (1.064×10−12, 4.107×10−12)
p3 -9.397×10−8 (-1.464×10−7, -4.149×10−8)
p4 0.001693 (0.000983, 0.002403)
p5 -21.2 (-24.18, -18.22)
c f(z) = p1z2 + p2z + p3 p1 -1.349×10−6 (-1.607×10−6, -1.091×10−6) 1
p2 1.084 (1.067, 1.101)
p3 -1942 (-2229, -1654)
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(a) Red PV versus x position, OD level 1. (b) Red PV versus x position, OD level 2.
(c) Red PV versus x position, OD level 3. (d) Red PV versus x position, OD level 4.
(e) Red PV versus x position, OD level 5. (f) Red PV versus x position, OD level 6.
(g) Red PV versus x position, OD level 7.
Figure 2.11: Parabolic fit (y = ax2 − 2xmaxa + c) of the PV versus the position along the x
axis at various OD levels, having fixed the maximum of the curves equal to the
central position of the scanner.
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Figure 2.12: Comparison between the parabolic curves fitted with 2 parameters and the point
of maximum fixed at the centre of the scanner (xmax=10.2 cm). The plotted
curves are relative to different OD levels and they are normalized to the maximum
PV of each curve.
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(a) Fit of the parameter a with the function f(z) = p1z4 + p2z3 + p3z2 + p4z + p5.
(b) Fit of the parameter c with the function f(z) = p1z2 + p2z + p3.
Figure 2.13: Fit of the parameter a and c of the parabola versus the maximum PV at various
dose levels.
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value. Then, a way to reduce these little variations could be the application of a filter on
the pixel values with the aim of reducing the noise.
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(a) Green PV versus x position, OD level 1. (b) Green PV versus x position, OD level 2.
(c) Green PV versus x position, OD level 3. (d) Green PV versus x position, OD level 4.
(e) Green PV versus x position, OD level 5. (f) Green PV versus x position, OD level 6.
(g) Green PV versus x position, OD level 7.
Figure 2.14: Mean PV in the green channel along the x axis for different OD levels. The PV
is normalized to its maximum value.
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(a) Blue PV versus x position, OD level 1. (b) Blue PV versus x position, OD level 2.
(c) Blue PV versus x position, OD level 3. (d) Blue PV versus x position, OD level 4.
(e) Blue PV versus x position, OD level 5. (f) Blue PV versus x position, OD level 6.
(g) Blue PV versus x position, OD level 7.
Figure 2.15: Mean PV in the blue channel along the x axis for different OD levels. The PV is
normalized to its maximum value.
32
Chapter 3
EBT3 calibration
In this chapter the calibration procedures applied in Plesio-Röntgen therapy and at Linac
are described. The necessity of two procedures comes from the reported energy dependence
of EBT3 in the KV range [26,27]. Instead, since it has been demonstrated the EBT3 energy
independence in the MV range in radiotherapy [25–27], a unique calibration has been used
both for Linac and Tomotherapy, which uses a 6 MV Flattened Filter Free (FFF) beam.
The first calibration has been set up because of the use of EBT3 for in vivo measurements
in patients treated with Plesio-Röntgen therapy. In second place, the EBT3 calibration
with a 6 MV photon beam from Linac has been necessary to use and analyze the EBT3 for
pre-treatment QA and in vivo measurements both at Linac and in Tomotherapy.
As reported in many studies, the answer to the question of what is the best channel
for dosimetry depends on the range of doses to be analyzed: the red channel gives good
results in the range of doses between 0 and 5 Gy, between 5 and 50 Gy the green channel is
preferred. Nevertheless, in general the red channel is the most used in clinical radiotherapy
for EBT3 calibration because it provides the better results in terms of signal to noise ratio
(SNR) [5,41,56,57]. For these reasons, the red channel calibration have been made both in
Plesio-Röntgen therapy and at the Linac. Furthermore, since the pre-treatment QA dose
maps obtained in radiotherapy are often complicated and contain high dose gradients, it
has been necessary to set up and try other calibration methods with data acquired at Linac.
During the last two decades, many studies have been published on how to extract, combine
and use the informations contained in all the three color channels setting up multichannel
dosimetry methods [5, 7, 49, 58–61]. Then, it has been decided to use a combination of
the green and blue channels with the method proposed by McCaw et al. in 2011 [4] and
applied also by Fiandra et al. in 2013 [3]. Moreover, the method for multichannel dosimetry
described by Peréz Azorín et al. [5] has been applied.
3.1 Calibration in Plesio-Röntgen therapy
Film pieces of 4x5 cm2 were cut from the same EBT3 film to perform some preliminary
measurements and then the calibration. EBT3 films are known to not perturb an incident
radiation beam, but in this case it was decided to investigate if a little attenuation of the
beam occurred at the energies used in Plesio-Röntgen therapy (60-100 kV in Plesio therapy
and 180-300 kV in Röntgen therapy). A ionizing chamber was placed in a block of solid
water to measure the ratio between the dose measured in presence and in absence of the film
sample. This attenuation measurement was made both in Plesio and in Röntgen therapy.
In the first case, a plan parallel ionizing chamber (PTW 23342) was located in a block of
solid water with a thick of 5 cm below the chamber. A circular applicator with a diameter
of 5 cm was employed and the film was fixed on the surface of the phantom, and at direct
contact with the applicator and the sensitive part of the chamber (see Fig. 3.1). This
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Figure 3.1: Experimental setup used during the preliminary measurements and the calibration
in Plesio therapy. For the measurements made before the calibration, the dose was
read by a plan parallel ionizing chamber with and without the film piece. When
present, the film sample was located at direct contact with the chamber and with
a circular applicator (5 cm diameter) during the measurements.
experimental setup was motivated by the fact that in Plesio therapy the MU are calibrated
such that 1 MU corresponds to 1 cGy on the skin, and it was decided to irradiate the film
under reference conditions. In this case the attenuation percentages were of 1.22% for filter
1 (60 KV) and of 0.7% for filters 2 and 3 (80 and 100 KV respectively).
The attenuation measurement was repeated in Röntgen therapy with 5 cm of solid
water below the chamber (Farmer PTW 30013) and 2 cm above, because here the MU are
calibrated such that 1 MU corresponds to 1 cGy at 2 cm of depth. The film was placed at
1 cm above the chamber, at 1 cm of depth in the phantom with respect to the radiation
source (see Fig. 3.2) and a square applicator with a dimension of 10x10 cm2 was used.
Here, the measurement was made for the filter 9, which corresponds to 300 kV. In this
case the attenuation percentage was of 0.04% in presence of the film, confirming that with
the increase of radiation energy the film becomes more transparent to the incident beam.
However, the attenuation at the energies used in Plesio therapy are low but not negligible,
hence they will be taken into account during the calibration measurements. For the sake of
clarity, the attenuation measurements are summarized in Table 3.1.
The calibration measurements have been set up for filters 1, 3 and 9, that correspond
to 60, 100 and 300 kV. Film pieces of 4x5 cm2 were irradiated with the same experimental
setup described above. The dose in correspondence of the film was measured during the
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(a) (b)
Figure 3.2: Experimental setup used during the preliminary measurements and the calibration
in Röntgen therapy. For the measurements made before the calibration, the dose
was read by the ionizing chamber with and without the film piece. When present,
the film sample was located at 1 cm of distance above the chamber (3.2a) and then
covered by another slab of solid water thick 1 cm (3.2b). The square applicator (10
cm dimension) was placed in direct contact with the slabs during the measurements
(3.2b).
Table 3.1: Resume of film attenuation measurements in Plesio-Röntgen therapy.
filter applicator k voltage percentage attenuation
Plesio therapy 1 circular (diameter 5 cm) 60 1.22%
2 circular (diameter 5 cm) 80 0.7%
3 circular (diameter 5 cm) 100 0.7%
Röntgen therapy 9 square 10x10 cm2 300 0.04%
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irradiation and reported at the depth of the film. For each calibration, 5 irradiation points
at different MU values were chosen (see table 3.2). Each film piece was read two times,
one before and one after the irradiation, according to the scanning protocol that has been
described previously. Moreover, in this case there was a further reading of the zero-light
transmitted image of an opaque sheet, taken after the scans of the unexposed (PV0,unexp)
and exposed (PV0,exp) films, respectively. This variation in the calculation of the net OD,
used for example by Fiandra et al. [3], has been implemented in order to investigate the
impact of this kind of correction on the estimated dose. According to this approach the net
OD in channel k corrected for the black becomes:
netODk,corr = log10
PVunexp,k − PV0,unexp,k
PVexp,k − PV0,exp,k (3.1)
Another variant has been introduced: the exposed films were read both at 3 h and at 22 h
after the irradiation, with the aim of comparing the readings with different post-irradiation
times.
In all the cases taken into account, dose has been fitted with respect to the net OD
in the red channel with a parabolic function (f(x) = p1x2 + p2x + p3) and the results
are summarized in Table 3.3. This choice has been motivated by the fact that the dose
distributions prescribed in this type of therapy are much simpler than those performed in
Linac and in Tomotherapy. Hence, the use of EBT3 films in Plesio-Röntgen therapy in
this work has been limited to the verification of in vivo skin dose. For this application, the
simplest and effective calibration in the red channel seems to be sufficient. Instead, the use
of more complicated methods to analyse calibration data, which combine more than one
channel together, will be motivated in the calculation of the dose matrix in pre-treatment
QA.
As can be appreciated from Figs. 3.3b, 3.4b and 3.5b, the differences between fits are
more accentuated when the dose decreases. Moreover, the absolute values of the percent-
age differences between the fitted dose and the expected dose (measured with the ionizing
chamber) decrease with the increasing dose. As can be noticed, at doses lower than 150
cGy the percentage error is higher for filter 1 (about 9 %), then it decreases for filters 3
(about 2-3 %) and 9 (0.5-2.5 %). As can be seen from the last column of Table 3.3 the
mean percentage errors in the entire range of doses are less than 1 % for filters 3 and 9 and
bit higher for filter 1, due to the larger deviation at very low doses in the latter case. The
doses commonly prescribed in clinic are 300-500 cGy, hence errors committed in practice
are lower 0.5 %. If comparing 3 h and 22 h readings, the results are quite well comparable
for the first two filters, but the average percentage error decreases of one order of magnitude
for filter 9, leading to prefer the 22 h reading. A final consideration regards the correction
for the black reading. In this case results are always better or equal to the not corrected
ones, leading to prefer this kind of approach if possible. However, this method requires two
additive readings to involve an improvement in the dose estimation less than 0.1%, thus
probably the complication introduced does not worth it.
3.2 Calibration in Linac
Film samples were cut (5x5 cm2) and irradiated with a 6 MV photon beam from a Linac
Synergy Agility, Elekta. They were placed at the isocenter of the accelerator at a source-axis
distance (SAD) of 100 cm and the field size at the isocenter was of 10x10 cm2. The films
were centered in a block of solid water thick 5 cm over and 5 cm below the film. Moreover,
a ionizing chamber (Farmer PTW 30013) placed at a depth of 6 cm was used to measure
the dose delivered to the film during the irradiation (see Fig. 3.6). To obtain a calibration
curve, the samples were exposed perpendicularly to the radiation beam in a dose range of
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Table 3.2: Calibration table in the Plesio-Röntgen calibration. The MU supplied during the
calibrations and the dose in correspondence of the film (measured through the
ionizing chamber) and corrected for its attenuation are reported.
filter 1 MU 73 146 300 500 1000
dose (cGy) 78.1 155.8 320.2 533.5 1178.9
filter 3 MU 100 200 300 500 1000
dose (cGy) 110.0 219.7 329.7 549.6 1099.9
filter 9 MU 70 200 300 500 700
dose (cGy) 73.5 209.9 315.0 526.1 735.9
Table 3.3: Results of the parabolic fits made in the Plesio-Röntgen calibrations. The estimated
parameters (p1, p2 and p3) and the R-square of the fit are reported. Moreover, the
last column shows the average percentage errors of the estimated dose with respect
to its expected value (measured with the ionizing chamber).
calibration data p1 p2 p3 R-square δdose(%)
filter 1 3h 7569 -1200 1112 0.9998 1.26
(2694, 1.244×104) (-4668, 2268) (542.2, 1682)
3h - black 6678 -1007 1082 0.9998 1.23
(2369, 1.099×104) (-4161, 2148) (549.5, 1615)
22h 7432 -1123 1064 0.9997 1.29
(2340, 1.252×104) (-4775, 2529) (458.6, 1669)
22h - black 6489 -903.1 1032 0.9998 1.23
(2241, 1.074×104) (-4043, 2236) (496.3, 1567)
filter 3 3h 3973 454.9 975.8 1 0.25
(2565, 5381) (-559.4, 1469) (808.9, 1143)
3h - black 3416 526.5 954.2 1 0.22
(2278, 4555) (-317.2, 1370) (811.6, 1097)
22h 3889 431.3 941.6 0.9999 0.38
(1690, 6087) (-1177, 2040) (672.5, 1211)
22h - black 3295 531.9 916.3 1 0.34
(1561, 5029) (-775, 1839) (691.5, 1141)
filter 9 3h 2913 932.6 923.6 0.9999 0.37
(181.4, 5645) (-697.6, 2563) (694, 1153)
3h - black 2490 953.8 908.5 1 0.32
(359.1, 4622) (-350.4, 2258) (720.2, 1097)
22h 1892 1472 823.3 1 0.07
(1153, 2631) (1023, 1921) (758.7, 887.9)
22h - black 1555 1458 807.2 1 0.05
(887.9, 2221) (1042, 1875) (745.7, 868.7)
37
(a)
(b)
Figure 3.3: Calibration curves (3.3a) and percentage errors (3.3b) in the red channel for filter
1 in Plesio therapy.
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(a)
(b)
Figure 3.4: Calibration curves (3.4a) and percentage errors (3.4b) in the red channel for filter
3 (100 kV) in Plesio therapy.
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(a)
(b)
Figure 3.5: Calibration curves (3.5a) and percentage errors (3.5b) in the red channel for filter
9 (300 kV) in Röntgen therapy.
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Figure 3.6: Experimental setup used during the calibration measurements in Linac. The film
sample is located at the isocenter of the accelerator with 5 cm of solid water above
and below. A ionizing chamber is placed at 1 cm below the film.
Table 3.4: Calibration table in Linac calibration. The MU supplied during calibration mea-
surements and the dose in correspondence of the film are reported.
MU 0 10 20 30 50 80 130 210 340 550 1000 1450 2350 3800
dose (cGy) 0.00 9.63 19.25 28.88 48.41 77.29 125.70 202.99 328.98 532.26 968.83 1402.56 2276.26 3683.92
0-40 Gy with 14 values. The absolute doses were determined according to the AAPM TG-51
protocol [63] and are summarized in Table 3.4 .
The film pieces were scanned before and after the irradiation, in order to have an offset
measurement to correct for film inhomogeneities. The post-irradiation reading was made
after 22 h from the exposure, in order to guarantee a stabilization of the film reading
output. They were read in the center of the scanner to avoid lateral artifacts of the scanner.
Moreover, with the aim of reducing the noise, each scan was repeated for three times and
readings were averaged at the end, obtaining a mean PV for each exposed film (PVexp)
and an average value for the correspondent offset (PVunexp). The ROI analyzed was a 5x5
mm2 square placed in the center of the film piece, obtaining for each film piece and for each
channel the mean signals exposed and unexposed. Then, for each channel k the net OD has
been estimated:
netODk = log10
PVunexp,k
PVexp,k
(3.2)
3.2.1 Red channel calibration
The dose points used for the calibration have been fitted with respect to the net OD es-
timated in the red channel. With the aim of obtaining the best agreement between the
fitted points and the experimental data, a number of functions have been tried. These were
polynomial, exponential, and power functions. Finally, the best compromise was to fit the
experimental points with two functions: a quadratic polynomial at low doses (<200 cGy),
and a fourth degree polynomial ad higher doses (≥200 cGy). The zero degree parameter of
the low dose curve was set equal to zero in order to have null dose when the net OD is zero.
y =
{
a1x
2 + a2x, x<200 cGy,
b1x
4 + b2x
3 + b3x
2 + b4x+ b5, x≥200 cGy.
(3.3)
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Table 3.5: Results of the fit in the red channel calibration.
fit function fitted parameters R-square
low doses (<200cGy) f(x) = a1x2 + a2x a1 979.1 (113.2, 1845) 0.9926
a2 901.4 (697.7, 1105)
high doses (≥200cGy) f(x) = b1x4 + b2x3 + b3x2 + b4x+ b5 b1 3.818×104 (5915, 7.044 ×104) 0.9994
b2 -5.655×104 (-1.171×104, 4048)
b3 3.264×104 (-6302, 7.158e+04)
b4 -5975 (-1.581×104, 3858)
b5 473 (-320, 1266)
Figure 3.7: Fit of the dose with respect to the net OD in the red channel. The experimental
points are represented in red, the low dose curve in pink (a1x2 + a2x), the high
dose fit in green (b1x4+b2x3+b3x2+b4x+b5) and the intermediate region average
between the two curves in black.
Furthermore, in the the transition region between the two functions, the curves were substi-
tuted by their means (in the region 120-330 cGy), as can be seen in Fig. 3.7. The results of
the fits have been summarized in Table 3.6. Moreover, the percentage differences between
experimental data and fitted points are reported in Fig. 3.8. As can be seen, the percentage
error for doses lower than 50 cGy is not negligible, having values sometimes much higher
than 10% and on average of 12%. Moreover, it decreases for higher doses, reaching an
average value of 0.2% for doses higher than 50 cGy. If considering the range of doses 0-200
cGy, the mean deviation is equal to 9%, and 0.48% above 200 cGy.
3.2.2 Green-blue channels calibration
The dose points used for the calibration have been fitted with respect to the net OD esti-
mated in the green/blue color channel. The approach used by Fiandra et al. in 2013 [3, 4]
has been employed considering the PV of the exposed and the unexposed images. This
method uses the blue channel to measure marker-dye corrections from unexposed film, and
the green channel to obtain desired dose values. The net OD measured both in the green
and blue channels is used with the aim of minimize response differences caused by anoma-
lies by means of the marker-dye correction. The optical density in the green and blue color
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Table 3.6: Results of the fit in the red channel calibration.
fit function fitted parameters R-square
low doses (<200cGy) f(x) = a1x2 + a2x a1 979.1 (113.2, 1845) 0.9926
a2 901.4 (697.7, 1105)
high doses (≥200cGy) f(x) = b1x4 + b2x3 + b3x2 + b4x+ b5 b1 3.818×104 (5915, 7.044 ×104) 0.9994
b2 -5.655×104 (-1.171×104, 4048)
b3 3.264×104 (-6302, 7.158e+04)
b4 -5975 (-1.581×104, 3858)
b5 473 (-320, 1266)
Figure 3.8: Percentage differences between fitted points and reference dose values (measured
with the ionizing chamber) in the red channel calibration.
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Figure 3.9: Fit of the dose with respect to the net OD in the green-blue channels. The exper-
imental points are represented in blue and the fitted curve in cyan (ax+ bxn).
channels are firstly converted in OD both in the exposed and unexposed images:
ODgb = log10
216
PVgreen
PVblue
= log10
216
PVgb
, (3.4)
where the PV are averaged in a ROI of 5x5 mm2 placed at the centre of the film piece for
each point of dose and for each color channel. The net OD mesured in the green/blue color
channel was defined by McCaw et al. [4]:
netODgb = ODexp,gb −ODunexp,gb = log10
PVunexp,gb
PVexp,gb
. (3.5)
Then, the function ax+ bxn was fit to dose as a function of the netODgb (see Fig. 3.9 and
Table 3.7). As can be seen in Fig. 3.10 the percentage differences between fitted values and
reference dose values (measured with the ionizing chamber during the irradiation) are on
average 22% under 200 cGy, reaching differences of about 50% for very low doses. Instead,
for doses higher than 200 cGy the percentage errors are on average 0.4%. If compared with
the errors committed in the red channel fit, the results in the green/blue calibration are worse
for doses lower than 200 cGy (on average 22% versus 9%). However the mean deviations
become comparable above 200 cGy: 0.48% for the red fit and 0.43% for the green/blue color
channels. It is evident that both the fits are not perfect, therefore a reasonable approach
to calculate the final dose from an OD map could be to average the two calibration curves.
In the pre-treatment QA the dose calculated from the red and the green/blue calibrations
will be compared with the dose computed by a mean of the two calibrations, hence taking
into account the informations from all the three color channels.
3.2.3 Multichannel film dosimetry
Recently, a number of studies have been carried out on multichannel dosimetry methods
using all the color channels to calculate the final dose matrix [5,7,49,58–62]. As reported in
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Table 3.7: Results of the fit in the green-blue channels calibration.
fit function fitted parameters R-square
f(x) = ax+ bxn a 3293 (2991, 3596) 0.9998
b 3.93×104 (3.289×104, 4.572×104)
n 3.05 (2.833, 3.267)
Figure 3.10: Percentage differences between fitted points and reference dose values (measured
with the ionizing chamber) in the green-blue channels calibration.
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Table 3.8: Results of the fits in the multichannel calibration. For each channel the fitted curve
was: D = p1,k−p2,kXkXk−p3,k .
color channel fitted parameters R-square
p1 p2 p3
red 1.391×107 325.3 3039 0.9998
(1.332×107, 1.449×107) (299, 351.6) (2903, 3176)
green 2.785×107 671.3 -1108 0.9997
(2.649×107, 2.922×107) (624.5, 718.1) (-1453, -763)
blue 3.783×107 1528 1310 0.9992
(3.408×107, 4.159×107) (1358, 1699) (595.7, 2025)
literature, the application of a multichannel optimization method strongly improves the re-
sults in patient specific QA in terms of gamma passing rates. This conclusion has been drawn
both for the Linac plans and the TomoTherapy irradiations, and the standard deviations
over repeated measurements indicate a larger variability when the single channel dosimetry
is employed, thus suggesting that the multichannel approach also impacts on measurement
repetability [7]. Among the methods employed, the procedure developed by Pérez Azorín
et al. [5], which refines the Mayer et al. method [61] and explicitly takes the information
of unexposed film into account, shows some improvements compared to other approaches.
Very good results have also been obtained by Mendez et al. [58], who developed a general-
ized channel-independent perturbation framework. Up to now, the method implemented by
Micke and Lewis [59, 60] is the only one commercially accessible (FilmQATMPro software,
Ashland Inc., Wayne, N.J. and at www.filmqapro.com). For this reason it is spreading in
many routine patient specific QA activities, but it has the disadvantage of being not freely
available. Hence, it has been decided to implement the method introduced by Pérez Azorín
et al. [5], motivated by its great results in terms of gamma passing rates and its improve-
ments compared with other multichannel methods. Moreover, the clarity and completeness
of the description of the method have allowed the writing of the correspondent Matlab code
(The MathWorks, Inc.).
The calibration data were fitted using the following calibration curve:
D =
p1,k − p2,kXk
Xk − p3,k , (3.6)
where Xk is the pixel value for each color channel (k=R, G, B), D is the dose, and pi,k are
the fitting parameters. This function has the advantage of being analytically invertible that
entails a considerable numerical advantage in this method. To perform the calibration, Xk
was evaluated from the exposed films in a central ROI of 5x5 mm2, the same that has been
used for the calibration in the red and in the green/blue channels. The results of the three
fits are shown in Fig. 3.11 and in Table 3.8.
According to this multichannel dosimetry method, ideally, the dose measurement for each
channel should be the same. Nevertheless, due to different response of the color channel
to inhomogeneities and uncertainties in the calibration curves itself, there are differences in
the dose response between the three channels. Following this reasonable assumption, the
scanned dose could be expressed as a function of the real dose applying a first order Taylor
expansion from the expected dose:
Dscank (i, j) = D(i, j) + αk(i, j)∆Xk(i, j), (3.7)
where i and j are the coordinate in the dose matrix, Dscank are the scanned dose matrices
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Figure 3.11: Fitted curves in the multichannel calibration. The fitted curve is represented
with a continuous line superimposed to experimental points.
for each channel k and the αk terms are defined as:
αk(i, j) =
∂D
∂Xk
∣∣∣∣
D(i,j)
(i, j). (3.8)
These terms can be analytically calculated from Eq. 3.6 and evaluated in the expected dose
D(i,j), hence obtaining:
αk(i, j) =
(p2,k +D(i, j))
2
p2,kp3,k − p1,k . (3.9)
The perturbation term ∆Xk can be expressed as the sum of two terms, one of which depends
on the color channel (βk) and the other is independent on the color channel and it takes
into account the perturbation sources that are common to the three channels (∆):
∆Xk(i, j) = ∆(i, j)− βk(i, j). (3.10)
In the above equation the minus sign is used for convenience. In this method it is assumed
that the βk correction term is independent on dose, hence it does not depend on the pixel
value and can be calculated from the unexposed film. Using Eq. 3.7 and 3.10, the final
expression of the expected dose becomes:
D(i, j) = Dscank (i, j) + αk(i, j)βk(i, j)− αk(i, j)∆(i, j) (3.11)
From now on, the pixel coordinate (i,j) will be implied in the equations. Ideally, Eq. 3.11
gives the real dose using any of the color channels if the perturbation terms are known. The
aim of the method is to estimate the dose by minimizing the difference between right- and
left-hand sides of the above equation using the least square method, then to find the values
of D and ∆ which minimize the functional Φ(D,∆):
Φ(D,∆) =
3∑
k=1
[Dscank + αkβk − αk∆−D]2. (3.12)
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Deriving this functional with respect to the variables D and ∆ and equating the derivatives
to zero, there will be a pair of nonlinear equation to solve:
F1(D,∆) =
∂Φ(D,∆)
∂D
=
(
3−
3∑
k=1
βk
∂αk
∂D
)
D
+
3∑
k=1
(
αk −Dscank
∂αk
∂D
− 2αkβk ∂αk
∂D
)
∆
+D∆
(
3∑
k=1
∂αk
∂D
)
+ ∆2
(
3∑
k=1
αk
∂αk
∂D
)
+
3∑
k=1
(Dscank + αkβk)
(
βk
∂αk
∂D
− 1
)
= 0,
(3.13)
F2(D,∆) =
∂Φ(D,∆)
∂∆
=D
(
3∑
k=1
αk
)
+ ∆
(
3∑
k=1
α2k
)
−
(
3∑
k=1
αk(D
scan
k + αkβk)
)
= 0.
(3.14)
The terms αk and βk need to be estimated in order to solve the system of equations.
The βk terms are assumed to be independent on dose, hence they can be calculated at
the beginning from the unexposed films and they will remain constant for the rest of the
multichannel analysis. To calculate the βk terms, an iterative scheme is used. Since the
dose for the unexposed films must be zero, the Eq. 3.11 can be solved imposing D=0 to
calculate βk for each channel at the iteration n:
β
(n)
k =

−D
scan
k,D=0
αk,D=0
+ ∆
(n−1)
D=0 (n>0),
−D
scan
k,D=0
αk,D=0
(n=0).
(3.15)
The starting values for the first iteration (n=0) assume ∆(0)D=0 equal to zero and at each new
step this term is calculated through equations 3.13 and 3.14, substituting D=0 and where:
αk,D=0 =
p22,k
p2,kp3,k − p1,k . (3.16)
The iterations proceede until convergence, i.e. up to the difference between βnk and β
(n−1)
k
becomes lower than a prefixed value.
The system of nonlinear equations (3.13 and 3.14) can be efficiently solved iteratively using
the Newton algorithm [64]. In order to begin the procedure, an initialization at the iteration
m=0 of D, ∆ and of the αk terms is needed. These terms are calculated in the approximation
in which αk is independent on dose, hence it is α
(m=0)
k = αk,D=0, and its derivative with
respect to D is null. In this condition the Eq. 3.13 and 3.14 become:
D(m=0) =
∑3
k=1D
′scan
k −W · (
∑3
k=1 αk,D=0D
′scan
k )
3−W ·∑k=1 αk,D=0 , (3.17)
∆(m=0) =
∑3
k=1 αk,D=0(D
′scan
k −D(m=0))∑3
k=1 α
2
k,D=0
, (3.18)
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where in the above equations D′scank and W are defined:
D
′scan
k = D
scan
k + αk,D=0βk, (3.19)
W =
∑3
k=1 αk,D=0∑3
k=1 α
2
k,D=0
. (3.20)
As can be verified, the approach employed by Mayer et al. [61] can be obtained from the
equations above by neglecting the βk correction terms.
Having obtained the initial values of the parameters αk and βk and of D and ∆, the equations
3.13 and 3.14 can be solved using the following iterations until convergence:
(
Dm
∆m
)
=
(
Dm−1
∆m−1
)
+
∂F1∂D ∂F1∂∆
∂F2
∂D
∂F2
∂∆
−1 · (F1(Dm−1,∆m−1)
F2(Dm−1,∆m−1)
)
. (3.21)
The second order derivatives of Φ(D,∆) can be calculated from the Eq. 3.13 and 3.14:
∂F1
∂D
=−D
3∑
k=1
βk
∂2αk
∂D2
+ ∆
3∑
k=1
{
2
∂αk
∂D
− 2βk
[(
∂αk
∂D
)2
+ αk
∂2αk
∂D2
]
−Dscank
∂2αk
∂D2
}
+D∆
3∑
k=1
∂2αk
∂D2
+ ∆2
3∑
k=1
{(
∂αk
∂D
)2
+ αk
∂2αk
∂D2
}
+ 3
+
3∑
k=1
{
βk
[
Dscank
∂2αk
∂D2
− 2∂αk
∂D
]
+ β2k
[(
∂αk
∂D
)2
+ αk
∂2αk
∂D2
]}
,
(3.22)
∂F2
∂∆
= D
3∑
k=1
∂αk
∂D
+ 2∆
3∑
k=1
αk
∂αk
∂D
+
3∑
k=1
{
αk
(
1− 2βk ∂αk
∂D
)
−Dscank
∂αk
∂D
}
, (3.23)
∂F2
∂D
=
∂F1
∂∆
, (3.24)
∂F2
∂∆
=
3∑
k=1
α2k, (3.25)
where ∂αk∂D and
∂2αk
∂D2
can be easily calculated from Eq. 3.9:
∂αk
∂D
=
2(p1,k +D)
p2,kp3,k − p1,k , (3.26)
∂2αk
∂D2
=
2
p2,kp3,k − p1,k . (3.27)
It must be noticed that this method corrects the light scattering phenomena through βk
terms, which describe the inhomogeneities of film-scanner assembly, but it consider that
these channel dependent inhomogeneities are independent on dose, which in principle is not
true [35, 51, 65]. Therefore, the dose matrix computed through the multichannel method
needs a parabolic correction as well as it is necessary when the red channel calibration is
employed. In fact, as it has been explained in the previous chapter, the need of a correction
for the light scattering phenomena becomes more important when the dose increase.
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Chapter 4
Pre-Treatment QA
In this chapter, with the purpose of validating GafChromic film dosimetry method and
understanding which of the EBT3 calibration approaches better responded to the range
of doses commonly used in radiotherapy, some films irradiated at Linac with different
standard fields have been compared with data measured through PTW 2D-Array 729
(http://www.ptw.de/3099.html) at Linac. Moreover, pre-treatment QA measurements have
been performed with EBT3, and absolute dose maps have been compared with TPS cal-
culations using γ-analysis [6], applied through VeriSoft Patient Plan Verification Software
(http://www.ptw.de/2406.html). Furthermore, the scanner parabolic correction was imple-
mented, tested through comparison between array measurements and film analysis, then
implemented in pre-treatment QA if necessary.
The film dosimetry method was developed and applied using a homemade Matlab code
(http://it.mathworks.com/) which provides for:
• opening the scans of exposed and unexposed images and averaging each group (see
Fig. 4.1a);
• if required by the user the average exposed and unexposed images are filtered and/or
corrected for the parabola effect;
• the OD map is centred at the isocenter by the user led by the laser markers signed at
the film edges (see Fig. 4.1b);
• the OD computed for each color channel is analysed using one of the film dosimetry
method to calculate an absolute dose map (see Fig. 4.1c).
4.1 Validation measurements
In the first part of this chapter, some preliminary measurements made to assess the per-
formances of GafChromic film dosimetry method at various dose levels have been set up.
The exposed films and their offsets have been scanned using the reading protocol described
in Chapter 2 and analysed through red channel calibration, green-blue channel approach
and using multichannel dosimetry method (see Chapter 3). Moreover an average of single
and double channels output has been computed (Mean R-GB) and the scanner parabolic
correction method has been implemented and tested.
During the validation measurements performed at Linac each film was located at the
isocenter of the accelerator (SAD 100 cm), centred in a block of solid water thick 10 cm
(SSD 95 cm). Then, each exposure was repeated on a PTW 2D-Array 729 placed such that
its effective point of measurement was at the isocenter. Since the array thickness was 2 cm
and being the effective layer of measurement of the chambers at 0.75 cm of depth, a block
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of 4.2 cm of solid water (SSD 95 cm) and a block thick 4 cm were positioned above and
below respectively (see Fig. 5.2).
4.1.1 Square field test
In first place, both the PTW array and EBT3 film were irradiated under same conditions
using a square field of 15x15 cm2 with 6 MV and 200 MU. The dose maps were generated
for the red channel calibration, the green-blue method, mean R-GB and for multichannel
method. With the aim of evaluating the general behaviours of these calibrations indepen-
dently on the particular dose value reached with this irradiation field, the simplest approach
was to normalize each dose map to its central value. Hence, the in-plane normalized dose
profiles are compared in Fig. 4.3. As can be noticed, all the methods present a good agree-
ment with experimental points. However, the multichannel approach and the red channel
seem to follow better measured data. If considering green-blue and Mean R-GB, there is a
soft underestimation. Nevertheless, when considering the cross-plane profiles at the isocen-
ter, there seems to be a worse accordance at the edges, probably for the light scattering
effect (see Fig. 4.4).
4.1.2 Low doses test (0-6 Gy)
A second test has been made to evaluate the film dosimetry method behaviour at various
doses in the range 0-6 Gy. The irradiaton was performed using a field dimension of 3x25
cm2, 6 MV and 1000 MU at Linac. Moreover, a wedge of 60◦ was employed with the
purpose of obtaining a wide range of doses during the same irradiation. The absolute dose
maps were compared to measurements performed using the PTW array through γ analysis.
Results were computed using local γ2D(3%,3mm) analysis (see Fig. 4.5). As can be seen
in Fig. 4.6, all the approaches have a great behaviour in the range of doses under study.
Nevertheless, if considering the overall behaviour of the profile, the green-blue shows the
best trend, as confirmed by the greater value of γ2D (see Table 4.1). Even if this strip was
read along the central axis of the scanner, for further information, Table 4.1 also reports the
γ2D results for the dose maps corrected for the parabola effect. As can be noticed, it does
not involve an improvement, with the exception of the multichannel, which reaches the 92
% of γ2D pass rate.
4.1.3 High doses test (2-10 Gy)
Another test was set up with the aim of assessing film dosimetry protocols responses both
in a higher dose range and in presence of a more extended field. In the first pair of tests
the parabolic correction was not necessary, especially in the second case, where a narrow
strip was read along the central axis of the scan. Nevertheless, in the cross-plane profiles,
parallel to the x axis of the scanner, obtained for the 15x15 field an overestimation of the
dose at the borders became to be noticed. As discussed in Chapter 2, till the doses remain
low the parabolic effect is negligible, and a correction would only introduce noise. Instead,
with increasing doses and when they are read far from the central axis, a correction for
this effect is needed both for the red channel and for the multichannel method, which only
computes a perturbation maps from the unexposed images.
Then, the PTW array was irradiated with 1600 MU, with a field 30x40 cm2 and using a
wedge of 60◦ to obtain a wide range of doses between 2 and 10 Gy. The EBT3 film, exposed
in the same conditions, was read through all the protocols both with and without parabolic
correction, with the aim of investigating on its efficacy. The results, expressed in terms of
γ(3%,3mm) are summarized in Table 4.1, showing a great improvement for the mean R-GB
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(a)
(b)
(c)
Figure 4.1: An example of the phases of the film dosimetry protocol. The scanned films are
open (4.1a) and averaged between multiple scans. The OD is computed (4.1b)
and analysed using a specific calibration method to obtain an absolute dose map
(4.1c).
Figure 4.2: Measurement setup during validation measurements performed with PTW 2D-
Array 729 at Linac.
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Figure 4.3: In-plane profile for 15x15 2 field, normalized to the central dose value.
Figure 4.4: Cross-plane profile of 15x15 2 field, normalized to the central dose value.
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and for the multichannel methods but not for the red channel. As can be seen in Figures 4.7-
4.10, the latter has a bad response to this test, hence it does not get better with a correction
that is based on some preliminary assumptions. If the pixel values are very far from the
real values that they had had if they would have read along the central axis, the parabolic
method combined with a fit that is weak in that range of doses fails. Instead, a more robust
approach, such as the multichannel method can benefit from a pixel value correction at the
border of the scanner, because it is performed before the optimization procedure provided
by this approach. Finally, the dose maps obtained through the multichannel approach both
without and with the parabolic effect correction are shown in Figures 4.12 and 4.11. As
can be noticed, they give an immediate idea of the presence of this effect, and on how it
increases with dose. Even if using a method that undoubtedly could be improved, it can be
appreciated the benefits resulted from its application.
4.1.4 10 fields test (0-24 Gy)
In this case a very large range of doses has been tested (0.2-24 Gy). This choice was
motivated by the objective to appraise the behaviour of the EBT3 dosimetric protocols
with a film containing at the same time very different optical densities (see Fig. 4.1b).
Firstly, an irradiation field with a dimension of 3x25 cm2 was used with a low number of
MU, then the field was reduced by 2.5 cm in the in-plane direction with a major number
of MU. This procedure was repeated for ten times, each of them with a field reduction of
2.5 cm, hence obtaining 10 squares with different doses. The MU were chosen to have very
different dose values in the various squares of 3x2.5 cm2. The plane in transversal and
coronal views is reported in Fig. 4.13 and the prescribed doses were: 10, 25, 50, 100, 200,
300, 500, 1000, 1500, 2347.8 cGy.
Moreover, to stress the method, the film strip was not read in the central axis of the
scanner, instead it was scanned along a direction parallel to it but far about 5 cm. Hence,
the dose map was obtained for red, mean R-GB and multichannel methods correcting before
the pixel values for the parabolic effect.
The analysed films dose maps and the array measurements were compared through γ-
analysis, whose distributions are shown in Fig. 4.14 and the in-plane absolute dose profiles
are superimposed in Fig. 4.15. Despite a failure at doses lower than 1 Gy and at the end of
the dose range under study, the behaviour of all the approaches seems to be quite good taking
into account the large range of doses that was tested. Nevertheless, the multichannel method
seems to confirm to follow better than the other techniques the array measurements in the
entire range of doses, especially when corrected for the parabola, which is really necessary
in this case. This conclusion is also evident from an inspection to the γ distribution (Fig.
4.14d) and to the results expressed in terms of local γ(3%,3mm) passing rates (Table 4.1).
To sake of completeness, in Table 4.1 are also reported the γ analysis results of the dose
maps without parabolic correction. As can be noticed, the correction does not involve an
improvement in the red channel, hence leading to worse results also in the mean R-GB.
This is probably because an underestimation of the red channel calibration at higher doses
is enhanced when correcting for the parabola, which has the effect of decrease the higher
doses when not read along the central axis.
Finally, from these validation tests it can be concluded that the multichannel method
is the one that best responses within an extended range of doses, and that the parabola
correction acts is effective in this approach when it needs to be applied (see mean results in
Table 4.1).
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(a) OD map
(b) dose map
(c) red channel (d) green-blue channels
(e) mean R-GB (f) multichannel
Figure 4.5: γ-analyses to compare films exposes at low doses with array measurements (4.5c-
4.5f) without parabolic correction. The OD map for the red channel (4.5a) and
the dose map computed with the multichannel method (4.5b) are also reported.
Table 4.1: Results of the local γ2D(3%,3mm) without low dose suppressions for the various
film dosimetry protocols in comparison with array measurements.
Validation test γ2D(3%,3mm)
Red Red-corr Green-Blue Mean R-GB Mean R-GB-corr Multichannel Multichannel-corr
Low doses - centred (0-6 Gy) 60.0 60.0 96.0 92.0 92.0 89.3 92.0
High doses - extended (2-10 Gy) 51.5 26.5 55.6 79.2 83.8 53.3 86.5
10 field - off-axis (0-24 Gy) 68.0 62.7 81.3 77.3 77.3 85.3 87.0
Mean 59.8 49.7 77.6 82.8 84.4 76.0 88.5
SD 8.3 20.2 20.4 8.0 7.4 19.7 3.0
55
Figure 4.6: Comparison of dose profiles between film dosimetry methods and array measure-
ments in the low doses test (0-6 Gy) without parabolic correction.
(a) Red (b) Red corrected
Figure 4.7: Local γ2D(3%,3mm) distribution for red channel method without (4.7a) and with
(4.7b) parabolic correction applied to the high dose test.
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Figure 4.8: Local γ2D(3%,3mm) distribution for green-blue analysis applied to the high dose
test.
(a) Mean R-GB (b) Mean R-GB corrected
Figure 4.9: Local γ2D(3%,3mm) distribution for mean R-GB analysis without (4.9a) and with
(4.9b) parabolic correction applied to the high dose test.
(a) Multichannel (b) Multichannel corrected
Figure 4.10: Local γ2D(3%,3mm) distribution for multichannel without (4.10a) and with
(4.10b) parabolic correction applied to the high dose test.
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(a) Cross-plane profiles of corrected (red curve) and uncorrected (cian curve) multichannel dose maps.
(b) γ2D to achieve a visual comparison between corrected and uncorrected multichannel dose maps.
Figure 4.11
58
(a) Multichannel dose map.
(b) Multichannel dose map corrected for parabolic effect of the scanner.
Figure 4.12: Comparison between multichannel dose maps with and without parabolic correc-
tion.
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(a) Transversal view in Pinnacle.
(b) Coronal view in Pinnacle.
Figure 4.13: Plan set up in Pinnacle to obtain 10 squares with different doses in the range
0.2-24 Gy. The prescribed doses in the center of each square were: 10, 25, 50,
100, 200, 300, 500, 1000, 1500, 2347.8 cGy. Fig. 4.13a reports the transversal
view, instead Fig. 4.13b reports the coronal perspective.
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4.2 Pre-treatment QA verifications
After the investigation on the reliability of the four dosimetric methods, made by compar-
ing the film analysis with an accurate measurement system such as the array of ionizing
chambers, they have been employed to analyse a collection of pre-treatment QA. In partic-
ular, thirteen verifications were performed in tomotherapy, conformal arc planned both in
Pinnacle and in Monaco, and in VMAT planned in Monaco.
The differences between film readings and dose distributions computed by the TPS
were compared in terms of local γ2D(3%,3mm) analysis, suppressing points under 10% of
maximum dose. Table 4.2 shows the γ2D results for the four dosimetric methods for the
various QA and compares the means and the standard deviations (SD) for all the QA
verifications subdividing them according to the planning technique employed. As can be
noticed, the multichannel method allows to achieve the best results, reaching an average γ2D
pass rate of 94.9 %. The mean R-GB also gives good performances, followed by green-blue
and red channels techniques. It is evident that more robust methods are able to achieve
good results in different treatment situations and with dissimilar software plannings. If
considering different TPSs, from these observations it can be noticed that Monaco seems
to be more accurate, even if only two cases have been taken into account. Instead, with
conformal arc in Pinnacle quite worse results are obtained. To take a couple of examples,
the γ2D distribution of a plan made in tomotherapy (patient 2) and a conformal arc in
Monaco are shown in Figures 4.16 and 4.17 respectively.
In addition, the same pre-treatment QA films were analysed employing the parabolic
correction for the red, the mean R-GB and the multichannel methods. In these types of dose
distributions the higher doses are usually located in the central part of the film, otherwise,
if the dose distributions are more extended they often contain low dose values. Hence,
the parabolic correction seems to be not necessary, excepted for those situations in which
films are read in a decentralized position on the scanbed. However, the effectiveness of
this correction in pre-treatment QA has been studied and the results are reported in Table
4.2. As can be observed from the mean results of γ2D, there is not an overall improvement
in any of the dosimetric protocols. However, if considering the trends in the subgroups,
the multichannel method and the mean R-GB take some benefits from the correction in
conformal arc, where also the red channel take some improvements, especially in Pinnacle.
Moreover, the tomotherapy plans, that are the more extended but with lower doses in this
case take no benefits from this correction.
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(a) red channel (b) green-blue channels
(c) mean R-GB (d) multichannel
Figure 4.14: 2D-γ distributions in the 10 fields tests, comparing different film analyses with
different protocols corrected for the scanner with array measurements.
Table 4.2: QA results in terms of local γ2D(3%,3mm) distribution, suppressing points under
10% of maximum dose. Passing rates are compared for the red, green-blue, mean
R-GB and multichannel methods and the mean and the standard deviation (SD)
of the results are reported.
Planning technique Patient Site of treatment γ2D(3%,3mm)
Red Green-Blue Mean R-GB Multichannel
Tomotherapy
1 H&N 95.9 92.7 96.8 98.0
2 H&N 82.7 71.7 97.9 94.4
3 H&N 82.8 84.3 93.2 87.1
4 H&N 95.4 84.8 98.1 99.4
mean 89.2 83.4 96.5 94.7
SD 7.5 8.7 2.3 5.5
Conformal Arc (Pinnacle)
5 SBRT brain 62.8 91.2 93 99.7
6 SBRT brain 82.6 70.8 80.1 83.7
7 SBRT lung 42.1 66.5 56.5 81.8
mean 62.5 76.2 76.5 88.4
SD 20.3 13.2 18.5 9.8
Conformal Arc (Monaco)
8 SBRT brain 97.3 76.7 93.7 98.3
9 SBRT brain 95.1 66.8 85.4 98.1
10 SBRT brain 85.5 98.1 93.6 99.6
11 SBRT brain 94.0 98.3 98.6 98.3
mean 93.0 85.0 92.8 98.6
SD 5.2 15.8 5.5 0.7
VMAT (Monaco)
12 SBRT brain 88.4 93.1 97.5 98.1
13 bladder 59.4 85.6 88.9 97.5
mean 73.9 89.4 93.2 97.8
SD 20.5 5.3 6.1 0.4
mean 81.8 83.1 90.3 94.9
SD 17.0 11.5 11.5 6.3
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(a)
(b)
Figure 4.15: Dose profiles comparison in the 10 fields test. The measurement superimposition
was performed both in linear scale (4.15a) and in semilogarithmic scale (4.15b),
in order to appreciate the discrepancies between different approaches both at low
and high doses. Here, the red, mean R-GB and multichannel are corrected for
the scanner parabola effect.
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Table 4.3: QA results in terms of local γ2D(3%,3mm) distribution, suppressing points under
10% of maximum dose. Passing rates are compared for the red, mean R-GB and
multichannel methods, all applying parabolic correction to the exposed images.
Moreover, the mean and the standard deviation (SD) of the results are reported.
Planning technique Patient Site of treatment γ2D(3%,3mm)
Red-corr Mean R-GB-corr Multichannel-corr
Tomotherapy
1 H&N 90.5 91.1 98.1
2 H&N 60.4 81.3 89.6
3 H&N 79.2 82.3 87.8
4 H&N 89.4 96.3 99.2
mean 79.9 87.8 93.7
SD 13.9 7.2 5.8
Conformal Arc (Pinnacle)
5 SBRT brain 66.6 93.4 99.5
6 SBRT brain 86.8 84.7 94.8
7 SBRT lung 56.0 54.6 85.9
mean 69.8 77.6 93.4
SD 15.6 20.4 6.9
Conformal Arc (Monaco)
8 SBRT brain 93.7 97.6 98.3
9 SBRT brain 88.4 97.3 95.7
10 SBRT brain 88.3 97.8 96.9
11 SBRT brain 92.5 97.9 95
mean 90.7 97.7 96.5
SD 2.8 0.3 1.4
VMAT (Monaco)
12 SBRT brain 87.5 97.6 94.6
13 bladder 61.2 88.5 97.3
mean 74.4 93.1 96.0
SD 18.6 6.4 1.9
mean 80.0 89.3 94.8
SD 13.8 12.1 4.4
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(a) TPS dose map. (b) In-plane dose profiles at the isocenter.
(c) γ2D for red channel. (d) γ2D for green-blue channels.
(e) γ2D for mean R-GB. (f) γ2D for multichannel.
Figure 4.16: Analysis of a QA OD map (4.16a) with different EBT3 dosimetric methods
through γ2D(3%,3mm) for patient 2 in tomotherapy (4.16c-4.16f). Moreover in-
plane profiles comparison of TPS dose (red curve) and EBT3 dose estimated with
mean R-GB (cian curve) are shown (4.16b).
65
(a) TPS dose map.
(b) In-plane dose profiles at the isocenter.
(c) γ2D for red channel. (d) γ2D for green-blue channels.
(e) γ2D for mean R-GB. (f) γ2D for multichannel.
Figure 4.17: Analysis of a QA OD map (4.17a) with different EBT3 dosimetric methods
through γ2D(3%,3mm) for patient 8 planned with a conformal arc in Monaco
(4.17c-4.17f). Moreover in-plane profiles comparison of TPS dose (red curve) and
EBT3 dose estimated with multichannel (cian curve) are shown (4.17b).
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Chapter 5
In vivo dosimetry
Clinical side effects to superficial structures are a major concern with radiotherapy patients
during the treatment of malignant disease by radiation, and for radiological protection. The
skin response to ionizing radiation limits the fully effective use of such radiation in cancer
therapy where relatively large areas of skin are exposed to penetrating X or gamma rays. As
a consequence, it becomes important to accurately determine the dose delivered to a patient
skin during radiotherapy owing to complications that can arise [48]. Clinical side effects
to superficial structures typically occur in 2-3 weeks after the beginning of radiotherapy
treatment, and may cause, if they are not tolerated by the patient, a treatment break [66].
Moreover, incidences of toxicities to superficial structures, such as dermatitis and alopecia
have been observed with IMRT treatments [67–69]. For these reasons, it is recommended
to reduce dose to the skin in optimization of radiotherapy plans, especially in IMRT. The
occurrence of complications in superficial structures as skin and mucosa in IMRT is possibly
related to increasing number of tangential beams compared with 3D-CRT, resulting in more
non-target tissues irradiated [67]. The dose to the skin could be higher in IMRT than in
3D-CRT also because, during the inverse planning, it is required to cover the planned target
volume (PTV) with the prescribed dose even in areas where build-up effect occur [70].
However, TPSs do not accurately model skin dose. One reason is the fact that voxels sizes
derived from patient CT images used in dose calculations are larger than skin dimensions.
This makes it difficult to for the TPS to accurately define the skin, and consequently leads
to inaccurate quantification of the skin dose. Another reason is the inability of most TPS
to accurately account for electron contamination, that has been shown by many authors to
contribute significant dose at the surface, therefore incorporation of this component in the
TPS is extremely important [48]. The inefficiency of the TPS in estimating the dose to the
skin or surface dose region has been subject of several studies. The build-up region dose
comprises a primary component of photons and electrons, and contamination electrons from
the treatment head and volume of air between the treatment head and patient. Excepted
for the primary component, the magnitude and importance of the skin dose contributed
from each of these components will vary with field size and shape. Therefore with the
widespread use of multileaf collimator (MLC) for field shaping and conformal therapy, the
dose contribution to the skin can vary significantly from one system to another depending
on the complexity of the MLC system, the variation in the gantry components, dosimetric
characteristics and modulation of the beams during delivery.
An overestimation of surface dose in phantom by the TPS of up to 14% has been reported
for helical tomotherapy and several studies in vivo have also demonstrated that the TPS
overestimate skin dose in tomotherapy treatments [72, 73,77].
Dosimeters that have been used to evaluate superficial doses in vivo an in phantom for
IMRT and tomotherapy include TLDs [71, 78], diodes [74], and MOSFETs [75–78]. Ra-
diochromic EBT films have many attractive characteristics that make them candidates for
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in vivo skin dosimetry such as high spatial resolution, near-tissue equivalence, and weak
energy response. Moreover, the equivalent depth in water of the effective point of measure-
ment for EBT radiochromic films has been determined as 153 µm [47], which is very close
to the clinically relevant depth for skin of 70 µm recommended by ICRP [1] and ICRU [2].
The aim of this chapter is to report the results of in vivo measurements performed during
radiotherapy treatments in tomotherapy, at Linac both with 3D-CRT and VMAT and in
Plesio-Röntgen therapy. Then, skin dose measurements, analysed through GafChromic
dosimetry, have been compared with TPS planned doses, investigating on factors possibly
related to discrepancies between expected and measured doses.
5.1 Measurement protocol
In film handling and storing the recommendations of the AAPM TG-55 report were followed:
gloves were used to avoid film soiling, exposure to light was minimized and films were kept
together to avoid differences in thermal histories [79]. Films of the same batch were cut in
pieces of 2x2 cm2 and each of them was enveloped with plastic film to facilitate their using
during in vivo measurements (see Fig. 5.2a).
The reading protocol adopted was the same described in Chapter 2, in particular each
piece was read three times before and after the irradiation. A consistent orientation was
maintained for all scans and the central axis was used for the reading in order to avoid a
non-uniform response of the scanner (see Fig. 5.2b). The remaining area of the glass tray
was covered by opaque radiographic films to reduce scattered light. The films were scanned
with 75 dpi resolution with 48-bit in RGB with all filters turned off and read 22 h after the
irradiation. The film readings were analysed using the red channel calibration because it
is more performant than the green-blue at doses equal or lower than 200 cGy, that are the
values commonly used for clinical fractions. Moreover, despite the multichannel method was
demonstrated to be more accurate than the others, it is more suitable to analyse extended
distribution of doses, then it seemed to be wasted to use an iterative method to read more
than one hundred film pieces. In fact other studies performed in vivo with EBT3 adopt the
same approach [46,80].
In order to compare the measured doses with expected values, the dose computed by
the TPS was used. In particular, given a point in the dose grid and a square centred on it
with a dimension of about 1 cm2, the expected dose in that point was computed averaging
the central value, the vertex values and the middle points on the sides of the square, hence
a mean of nine points of dose was computed. At the same time the mean PV of each film
piece was computed with ImageJ using a ROI of 1 cm2 centred in the film piece (see Fig.
5.1). This approach was used both for the measurements on phantom and in vivo. The
comparison between EBT3 and TPS expected doses will be made as follows [46,80]:
EBT3− TPS(%) = 100 · EBT3dose − TPSdose
TPSdose
. (5.1)
5.2 Preliminary measurements on phantom
With the aim of assessing the reproducibility of the measurements, the stability of the
response of different film pieces exposed to the same radiation field, and to evaluate the
agreement between film measurements and TPS expected doses, a set of measurements on
the Cheese Phantom (www.accuray.com) were performed.
In first place, a tomotherapy test plan was optimized to give 10 Gy in 5 fractions to
three circular superficial PTV in the Cheese. The plan was computed through a dose grid
with a fine resolution, which in tomotherapy means having the same resolution of the the
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Table 5.1: Summary of the results for preliminary tests on Cheese Phantom with EBT3 sam-
ples located on its surface (right, anterior and left in tomotherapy; anterior at
Linac). Moreover the percentage deviations of the EBT3 readings with respect to
the TPS values are reported.
Machine Film position EBT3 measured dose (cGy) TPS dose (cGy) EBT3-TPS (%)
Tomotherapy Right 126.7 ± 2.9 134.5 ± 0.3 -5.8
Anterior 127.8 ± 3.3 175.0 ± 0.2 -27.0
Left 124.8 ± 2.6 161.0 ± 0.3 -22.5
Linac Anterior 126.1 159.0±3.9 -20.7
CT images used fot the planning, that was 0.16x0.3x0.16 cm3 in this case (see Fig. 5.3).
This choice was motivated by the fact that thomotherapy plans are usually computed with
a fine grid, hence it was decided to assume the same conditions that will be present in the
in vivo case. Three superficial positions on the surface of the Cheese Phantom (see Fig.
5.4) were chosen to measure the film readings for five times. Then, the mean and standard
deviation of the film readings were evaluated. In order to have a reference dose value during
the film measurements, two ionizing chambers were used to measure the dose in two points
of the phantom to control the stability of the experimental conditions and the accordance
with the expected dose.
The results of these measurements are summarized in Table 5.1. As can be noticed,
the mean deviations between film readings are of 3 cGy, corresponding to about the 2% of
the absolute dose. Hence, it seems to be a good reproducibility between the measurements
and a great accordance between the reading of different EBT3 samples exposed to the
same plan fraction. Moreover, the TPS expected doses were estimated with the method
described above, considering a square with a dimension of about 1 cm2. In all the cases
taken into account the TPS overestimates the measurements of about the 23%. This trend
is in accordance with other results reported in literature.
Moreover, a measurement with an EBT3 film fixed on the Cheese surface was performed
at Linac in order to compare the film reading with the TPS estimated value. A field 10x10
cm2 with SSD 85 cm and energy of 6 MV was used. Even in this case an overestimation of
the TPS occurs, as shown in Table 5.1.
Secondly, an estimation of the MVCT contribution in Tomotherapy and of the cone
beam CT (CBCT) at Linac was performed using EBT3 pieces fixed on Cheese surface in
the same three positions used above. The measurement of the dose contribution on surface
of the CBCT was of 6.99 ± 0.09 cGy, instead the MVCT contribution was of 1.03 ± 0.03 cGy.
These evaluations were necessary since treatment fractions are often supplied after MVCT
or CBCT, hence some in vivo measurements contain this dose contribution. However, these
preliminary measurements demonstrated that this dose is negligible with respect to the
treatment componenent, which is of the order of 100 cGy, for Tomotherapy treatments,
instead it will be subtracted for patients treated at Linac.
5.3 Skin dose measurements
An evaluation of skin dose for patients treated with three radiation therapy have been per-
formed: Tomotherapy, 3D-CRT, VMAT and electron beams at Linac, and Plesio-Röntgen
therapy. A total of 21 patients were recruited, selecting those plans regarding superficial
lesions. In Plesio-Röntgen only cutaneous lesions are usually treated, instead in tomother-
apy were chosen five head and neck (H&N) and two brain plans having tumour lesions very
close to the skin and one patient with a sarcoma at the right thigh. Moreover, five breast
cancers, four treated with 3D-CRT and one with VMAT and two cutaneous lesions treated
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with electron beams were considered. Finally EBT3 measurements were made on a patient
treated with 180 kV in Röntgen therapy and on five irradiated with 60 kV in Plesio therapy.
Both in tomotherapy for superficial and cutaneous lesions and in kV range treatments,
an in vivo monitoring of skin dose could be important to prevent overdosage effects during
the treatment. In fact, in Plesio-Röntgen therapy the prescribed dose and MU can easily be
modified during therapy if necessary, and in tomotherapy it would be possible to readapt
the plan to avoid undesired effects such as alopecia and dermatitis. Moreover, if considering
breast tumours, the effect that usually occur is a cutaneous redding in the very last fractions
of the plan, hence the utility of EBT3 in adaptive plans is more limited. Nevertheless, it
was chosen to consider such cases in this study with the aim of having the possibility to
compare in vivo measurements with EBT3 between different types of plans and irradiation
techniques, and tanking into account varying positioning conditions.
In H&N and brain plans the film measurements were performed locating the EBT3
pieces in fixed positions in the inner part of thermoplastic masks (see Fig. 5.5). Conversely,
at Linac and for cutaneous lesions both in tomotherapy and in kV treatments, the film
pieces were positioned directly on the skin of the patients, helped by laser position or using
other reproducibles points, such as scars of tatoos (see Fig. 5.6). Regarding breast lesions
treated with 3D-CRT, films were positioned at the isocenter, at the border of the light field
and in correspondence of the medial tatoo. In the case of VMAT treatment, dose was also
monitored in correspondence of the collarbone.
The measurements were compared with expected dose estimated with the method pre-
viously described from the TPS dose grid for thomoterapy and Linac plans (see Figures. 5.7
and 5.8). Instead, the comparison in Plesio-Röntgen therapy was performed with prescribed
doses at the center of the lesions.
The results of in vivo measurements are reported in Tables 5.2-5.4. Looking at the overall
results, the average deviations of EBT3 measurements from expected values of TPS range
from 17.7% for Linac treatments to 3.8% for Plesio-Röntgen therapy. Instead Tomotherapy
is located at an intermediate position, reaching a mean of 11.6%. Moreover the mean
percentage error in EBT3 measurements are equal to 9.2% in Linac, 2.6 % in Tomotherapy
and 1.3% in Plesio-Röntgen treatments. The last two results are in great accordance with
the 2% of EBT3 variability estimated on phantom, confirming a good reproducibility also
in vivo. Instead, the worse results obtained in Linac in vivo measurements are motivated
by a more difficult positioning in these type of treatments, where thermoplastic masks are
not employed, and remembering that these treatments regard an area sensible to breathing
movements.
More in detail, if considering measurements on breasts treated with 3D-CRT, the devi-
ations from the TPS are on average smaller for the measurements made at the isocenter, as
expected. Instead, the edge and the median tatoo seem to be more uncertain to estimate
skin dose. A motivation of this trend for the edge point is the more difficult repositioning
of the film, being more affected by the re-positioning of the breast, and because it is at
the border of the irradiating field. Instead the median point measurements, where the po-
sitioning has a good reproducibility, are probably effect by the effect of the edge fields. In
these plans, there were some difficulties in re-positioning the film due to patient overweight,
instead for patient n. 4, where this was not a problem, the measurements are quite better
than the others. A better accordance there is for electron treatments, probably due to the
presence of the bolus, which moves the EBT3 point of measurement more in depth, leading
to a better accordance with the TPS, and for VMAT. Nevertheless, the number of patients
taken into account is too small to conclude something about different TPS performances
in calculating dose in the build-up region. In addition, the better agreement achieved in
tomotherapy is problably motivated by the presence of thermoplastic masks, which aid the
film re-positioning in each fraction very much. In addition, the best agreement with ex-
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Table 5.2: In vivo measurements with EBT3 made in radiotherapy treatments at Linac. Here,
the number of the patient (Pat.), the dose per fraction (dose/fx) and the number
of measurements (N) reported.
Pat. Treated site Plan (TPS) Dose/fx(cGy) Point N EBT3 dose (cGy) TPS dose (cGy) TPS SD (%) EBT3-TPS (%)
1 breast dx 3D-CRT(Pinnacle) 200 iso 4 141.5 ± 3.8 124.5 ± 20.1 16.1 13.7
med 4 63.0 ± 22.1 41.6 ± 9.9 23.8 51.6
edge 4 62.7 ± 37.1 129.3 ± 16 12.4 -51.5
2 breast dx 3D-CRT(Pinnacle) 200 iso 4 162.6 ± 4.9 151.7 ± 33.1 21.8 7.2
med 4 129.0 ± 18.0 181.8 ± 20.5 11.3 -29.0
edge 4 175.4 ± 7.1 150.9 ± 32.8 21.7 16.2
3 breast dx 3D-CRT(Pinnacle) 200 iso 3 108.2 ± 5.2 136.8 ± 12.6 9.2 -20.9
med 3 66.0 ± 3.8 55.1 ± 8.1 14.7 19.9
edge 3 142.9 ± 1.8 151.7 ± 14.7 9.7 -5.8
4 breast sx 3D-CRT(Pinnacle) 275 iso 3 136.8 ± 1.0 131.3 ± 18.2 13.9 4.2
med 3 103.1 ± 1.2 102.2 ± 27.5 26.9 0.9
edge 3 137.2 ± 2.0 127.8 ± 24.7 19.3 7.4
5 breast+collarbone dx VMAT 200 iso 3 120.5 ± 12.7 116.0 ± 53.7 46.3 3.9
dx 3 124.3 ± 6.1 138.0 ± 48.0 34.8 -9.9
collarbone 3 59.1 ± 3.9 98.4 ± 25.0 25.4 -39.9
6 hip dx electrons (Pinnacle) iso 1 179.3 196.9 ± 3.9 2.0 -8.9
7 hip dx electrons (Pinnacle) iso 2 178.2 ±1.3 198.3 ± 3.9 2.0 -10.1
Mean of the absolute values 17.7
of EBT3-TPS (%)
pected measurements is reached for Plesio-Röntgen therapy, surely because it is the most
simple type of treatment, which is not affected by many error sources that on contrary are
present in the other in vivo measurements. Moreover, in Plesio therapy the calculation of
prescribed dose is based on measurements that are directly performed on surface, hence the
common TPS errors are not present in this type of treatment.
Moreover, opposite to the results reported in literature, according to which the TPS
always overestimates the measured dose, in this study there is not a defined trend about the
overestimation of the TPS. In fact, especially in Linac measurements, the measurements
are sometimes lower and other times higher than calculated values. Instead, in Plesio-
Röntgen therapy in general the measured dose is a bit lower than the prescribed one, and in
tomotherapy in general the TPS underestimates the measurements, excepted for the unique
treatment performed without a positioning mask.
Finally, the measurements of a couple of patients treated with Plesio therapy (patients
16 and 17) have been analysed using different calibrations, in order to make a comparison
between the different readings. The calibration in Plesio-Röntgen therapy in the red channel
was performed both at 3h and 22 h after the irradiation, with and without the use of a black
reading(see Chapter 3). Hence, these calibration curves have been used to analyse the net
ODs of the the film pieces exposed during Plesio treatments with filter 1 (patient 16) and
with filter 3 (patient 17). The calibration performed for filter 9 was not used, since there
were no patients recruited with this type of treatment. The measurements are reported in
Table 5.5. Even if the 22 h calibration leads to a better accordance with prescribed dose
with respect to the 3 h analyses, the results are quite comparable. Moreover, both for 3
h and for 22 h readings, the accordance is better using the black, but the improvement is
really poor. These considerations lead to prefer an easier calibration after 3 h without black
reading.
5.4 Final assessments
Motivated by the good agreement achieved in tomotherapy measurements with TPS es-
timated doses, and by the trend observed regarding an underestimation of the TPS skin
dose, contrary to results reported in literature, a final test was set up. A thermoplastic
mask was built ad hoc for the Cheese Phantom (see Fig. 5.9) and some measurements were
made on the surface of the phantom both in presence and in absence of the mask both in
tomotherapy and at Linac.
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Figure 5.1: Schematic picture exemplifying the estimation of dose from the TPS dose grid.
The central point value is averaged with the other eight points of doses around.
The grid cubes are not in scale with respect to the CT image and its contours only
for demonstrative reasons.
Table 5.3: Summary of in vivo measurements with EBT3 performed during tomotherapy treat-
ments. Here, the number of the patient (Pat.), the dose per fraction (dose/fx) and
the number of measurements (N) reported.
Pat. Treated site Plan (TPS) Dose/fx (cGy) Point N EBT3 dose (cGy) TPS dose (cGy) TPS SD (%) EBT3-TPS (%)
8 H&N IMRT (Tomo) 200 sx 1 107.3 90.9 ± 2.1 2.3 18.1
dx 1 117.1 85.0 ± 0.1 0.1 37.8
9 H&N IMRT (Tomo) 200 sx 1 94.3 92.2 ± 2.1 2.3 2.3
dx 1 83.8 83.8 ± 0.1 0.1 0.0
10 H&N IMRT (Tomo) 200 center 6 170.5 ± 4.8 168.6 ± 0.1 0.1 1.1
11 H&N IMRT (Tomo) 200 sx 5 57.5 ± 4.9 53.3 ± 0.1 0.2 7.9
dx 5 95.4 ± 5.6 93.2 ± 0.1 0.1 2.3
12 brain IMRT (Tomo) 200 sx 4 64.4 ± 3.9 64.3 ± 0.9 1.4 0.2
dx 4 149.3 ± 2.8 146.5 ± 5.1 3.5 1.9
13 H&N IMRT (Tomo) 200 sx 1 133.0 124.8 ± 0.1 0.1 6.6
center 1 140.6 174.1 ± 0.1 0.1 -19.3
14 brain IMRT (Tomo) 200 center 3 119.1 ± 7.4 96.6 ± 0.2 0.2 23.3
dx 3 144.3 ± 3.3 106.2 ± 0.2 0.2 35.9
15 sarcoma IMRT (Tomo) 200 red dx 5 136.2 ± 3.7 135.3 ± 0.3 0.2 0.6
scar dx 4 136.3 ± 1.2 155.2 ± 1.2 0.8 -12.2
green dx 4 139.4 ± 6.7 165.9 ± 0.2 0.1 -16.0
Mean of the absolute values 11.6
of EBT3-TPS (%)
Table 5.4: Summary of in vivo measurements with EBT3 performed during Plesio-Röntgen
treatments. Here, the number of the patient (Pat.) and the number of measure-
ments (N) reported. (∗)This prescribed dose value is referred to 5 mm of depth, and the
measurement is affected to a further error due to the presence of a lead template that was
not considered by the TPS.
Pat. Treated site Plan Point N EBT3 dose (cGy) Prescribed dose/fx (cGy) EBT3-Prescribed (%)
16 head Plesio-Filter 1 (60 kV) iso 2 280.3± 1.7 300.0 -6.6
17 eye sx Plesio-Filter 3 (100 kV) iso 2 298.6 ±0.0 300.0 -0.5
18 head Plesio-Filter 1 (60 kV) iso 4 285.6 ±13.1 300.0 -4.8
19 foream Plesio-Filter 1 (60 kV) iso 4 298.7± 7.9 300.0 -0.4
20 ear dx Röntgen-Filter 6 (180 kV) iso 1 299.1 315.0(∗) -5.0
21 chest Plesio-Filter 1 (60 kV) iso 1 552.3 500.0 10.5
Mean of the absolute values 4.6
of EBT3-Prescribed (%)
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(a)
(b)
Figure 5.2: EBT3 film pieces of 2x2 cm2 cut and prepared with a plastic film envelop to
perform in vivo measurements (5.2a). Reading position of the film pieces along
the central axis of the scanner (5.2b).
Table 5.5: Comparison of some EBT3 in vivo measurements performed during Plesio-Röntgen
treatments read with different calibrations in the red channel. The readings after 3h
and 22h from the irradiation, with and without the use of the black, are compared
with the prescribed doses.
Pat. Site Plan N EBT3 dose (cGy) Prescribed EBT3-Prescribed (%)
3h 3h-black 22h 22h-black dose/fx (cGy) 3h 3h-black 22h 22h-black
16 head Filter 1 2 277.2 ± 4.5 277.5 ± 4.8 280.3 ± 1.7 280.6 ± 1.3 300.0 -7.6 -7.5 -6.6 -6.5
17 eye sx Filter 3 2 294.4 ± 6.6 294.5 ± 6.6 298.6 ± 0.0 298.6 ± 0.5 300.0 -1.9 -1.8 -0.5 -0.5
Mean of EBT3-Prescribed (%) -4.8 -4.7 -3.6 -3.5
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Figure 5.3: Tomotherapy plan used for the preliminary measurements performed with the
Cheese Phantom.
In tomotherapy the experimental conditions occurring during in vivo measurements in
H&N and brain treatments were reproduced. In order to avoid any source of errors due to
phantom re-positioning, these measurements were performed in a unique irradiation, being
the Cheese covered by the mask only for a part. Then, a film was placed on the part of
surface not covered by the mask, and another was fixed below it. The plan was created ad
hoc with some superficial PTV having a prescribed dose of 2 Gy per fraction, reproducing
the same conditions of in vivo measurements (see Fig. 5.10).
Furthermore, a similar measurement was set up at Linac, with two fields, one impacting
perpendicularly to the film placed on the surface of the cheese and covered by the mask,
and then another hitting on a part free by the mask. The number of MU of each beam was
chosen such that the expected skin dose was similar to the values that on average occur in
vivo. The resolutions of dose grids were chose equal to those occurring in vivo, so fine in
tomotherapy, and 0.3x0.3x0.3 mm2 in Pinnacle.
The results of these measurements are reported in Table 5.6, where they are compared
with TPS expected doses. As can be appreciated, the accordances between EBT3 and
measurements improve when the thermoplastic mask is used. This is motivated by the fact
that the EBT3 measure in a point that is more in depth, hence there is a better accordance
with the TPS, that fails on the surface, as reported in literature. These experimental
assessments on phantom provide a further explanation of the worse results obtained at Linac
without masks. Moreover, in tomotherapy measurements, where the accordance with the
TPS in presence of mask is excellent, it seems to be reproduced the trend reported in table
5.3, where the TPS on average overestimates the measurements performed without mask
in Pat. 15 and underestimate the others with mask, but having a better agreement with
the TPS. Nevertheless, the number of cases taken into account in vivo, especially without
mask, and the final measurements performed on phantom should be repeated to obtain a
better statistic to confirm a trend. As a consequence, further studies and measurements
seem to be necessary to investigate on the behaviour of in vivo skin dose under different
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Figure 5.4: Experimental setup employed during preliminary measurements on the surface of
Cheese Phantom. Three films are located in right, anterior and left positions and
two ionizing chambers were used to control the dose. In the figure are visible only
the right and the anterior films.
Figure 5.5: An example of in vivo measurement setup with EBT3 in tomotherapy using a
thermoplastic mask.
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(a)
(b)
Figure 5.6: Film pieces positioned on patient skin in Plesio therapy (5.6a) and for breast
treated with 3D-CRT at Linac (5.6b). In the latter case, films are placed at the
isocenter, at the edge of the light field and in correspondence of the medial tatoo.
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Table 5.6: Summary of the results for final tests on Cheese Phantom with EBT3 samples
located its surface both in presence and in absence of thermoplastic mask, in To-
motherapy and at Linac.
Machine (TPS) Experimental condition EBT3 dose (cGy) TPS dose (cGy) EBT3-TPS (%)
Tomotherapy without mask 124.7 174.6 -28.6
with mask 137.0 136.1 0.7
Linac (Pinnacle) without mask 126.1 159.0 -20.7
with mask 122.5 146.3 -16.3
experimental conditions.
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(a) (b)
Figure 5.7: Film positioning in breasts treated with 3D-CRT displayed with TPS Pinnacle.
Yellow arrows point to chosen measurements positions of isocenter (iso) and medial
tatoo (med, 5.7a) and the edge of the field (5.7b).
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(a) H&N plan in tomotherapy.
(b) Brain plan in tomotherapy
(c) Sarcoma plan in tomotherapy.
Figure 5.8: Film positioning in tomotherapy plans displayed with TPS Tomotherapy. Yellow
arrows point to chosen points of measurement: the center of the larinx in a H&N
(5.8a), a point in the right and one in the center for a brain plan (5.8b) and two
points on the skin of a patient treated without the use of the thermoplastic mask
having a sarcoma (5.8c).
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Figure 5.9: Final EBT3 measurements performed on Cheese Phantom using a thermoplastic
mask built ad hoc for it.
Figure 5.10: Tomotherapy plan used for EBT3 measurements performed on Cheese Phantom
simultaneously with and without mask. The yellow arrow points to the surface
position covered by the mask, instead the red one is referred to a point not covered
from the immobilization device.
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Chapter 6
Discussion of the results and
concluding remarks
The aim of this thesis was to describe the use of GafChromic EBT3 films for pre-treatment
QA applying both single channel and multiple channel methods, and to present the analysis
of skin dose measurements using radiochromic film as in vivo dosimeter. EBT3 represent
one of the most powerful tools to perform pre-treatment QA verifications and in vivo mea-
surements, due to their high spatial resolution, energy independence in the MV range in
radiotherapy, angular independence, easy handling and self-developing.
In first place a characterization of the scanner response at different optical densities and
in correspondence of various positions of the scanbed was made. All the channels responses
showed a weak and negligible variation along the scan direction, instead, perpendicularly to
the scan direction there were higher PV deviations. For the red channel it was measured and
fitted a parabolic trend in the mean pixel value reading, with a maximum in correspondence
of the central axis of the scanner. When the same film piece was read at the border of the
scanner instead that on the central axis, the mean pixel value reached even the 20% less than
the central value, when an high OD film was considered. Even if this effect was attenuated
for lower ODs, and it became negligible when an unexposed film was read, a correction for
this parabolic effect seemed to be necessary. For this reason, a practical method, based on
parabolic fits performed at various OD levels, was developed and implemented in a Matlab
code. Instead, the green and blue channels showed lower deviations from the readings on
the central axis, that were estimated to be about 1-3%, hence no correction methods were
implemented for these channels.
Secondly, GafChromic EBT3 films were calibrated in the three channels and various
dosimetric methods were developed to obtain an absolute dose measurement from the OD
map read with the CCD scanner. All the approaches utilized both the scans of the un-
exposed and exposed images, in order to take into account film inhomogeneities. The red
channel calibration, a method combining both the green and the blue channels [3, 4], the
mean of these two methods and a multichannel iterative algorithm [5], were implemented
through homemade codes in Matlab. The performances of all the dosimetric approaches
were assessed analysing a number of films irradiated using test fields and then they were
applied on thirteen pre-treatment clinical QA. The single red channel and the double chan-
nel techniques showed moderate performances in terms of γ2D(3%,3mm) pass rates, leading
on average to 82% and 83% respectively on the group of QA taken into account. Instead
the mean of these two methods led to an average result of 90%, showing a more stable
response in the range of doses considered, and the multichannel method achieved the best
average performance of 95%. Moreover, the parabolic correction did not improve the mean
results for the red, the mean R-GB and the multichannel approaches, probably because in
pre-treatment QA the dose maps analysed contain higher dose levels only in the central part
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of the film, that is read in the central part of the scanner, where no correction is needed.
Then, the applicability of EBT3 to monitor in vivo skin dose has been assessed. In vivo
measurements were performed during radiotherapy treatments in tomotherapy, at Linac
both with 3D-CRT and VMAT and in Plesio-Röntgen therapy. Then, skin dose mea-
surements, analysed through single red channel dosimetry, have been compared with TPS
planned doses. Overall EBT3 measurements showed a good reproducibility, even if the
measurements made without thermoplastic masks had more re-positioning problems. Nev-
ertheless, the comparison between measurements and TPS estimated dose values was more
delicate. The average deviations of EBT3 measurements from expected TPS values ranged
from 17.7% for Linac treatments to 4.6% for Plesio-Röntgen therapy. Instead Tomotherapy
was located at an intermediate position, reaching a mean of 11.6%. In the measurements
performed at Linac, the TPS sometimes overestimated and other times underestimated the
measurements, instead in tomotherapy a more delineated trend was observed, showing an
underestimation of the TPS skin dose, contrary to results reported in literature. Since it
was revealed when thermoplastic masks had been used, but not for in vivo measurements
made directly on skin in tomotherapy, a set of final measurements on the Cheese Phantom
were set up with a mask built ad hoc for it. Here, EBT3 readings showed a similar trend: a
worse accordance with the TPS for measurements without the mask, and a better agreement
in presence of the mask leading to a soft underestimation by the TPS.
In conclusion, this study has confirmed the importance of GafChromic EBT3 films in
pre-treatment QA in radiotherapy and it has provided new in vivo data, showing that
they are suitable detectors for surface dose in vivo monitoring. In vivo skin measurements
with EBT3 films are a useful tool for QA in radiotherapy treatments, as they lead to a
quantification of dose in areas where the TPS may not be accurate.
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